IDENTITAS MAHASISWA
1
SAMBUTAN
2
KATA PENGANTAR
Fastabiqulkhaerat.
TTD
3
METODE BIMBINGAN EVALUASI
STASE Manaj
Laporan TOTAL
CBD BST TutorialK RefleksiK K JournalR OMP DOPS Mini C OSLER OSCE
(COC)
Keterampilan Dasar Praktik
Kebidanan 1 3 0 0 0 0 0 2 1 0 0 0 7
4
STASE II
i
STASE II
ASUHAN PRANIKAH DAN PRAKONSEPSI
A. TUJUAN
1. Tujuan Umum
Memberikan pengalaman belajar klinik pada mahasiswa dalam
lingkup asuhan remaja yang meliputi kesehatan fisik, mental
pranikah, persiapan kehamilan sehat dan kesehatan reproduksi
2. Tujuan Khusus
a. Mampu melakukan asuhan kebidanan pada pranikah dan prakonsepsi
secara holiktis, komprehensif dan berkesinambungan yang didukung
kemampuan berpikir kritis, rasionalisasi klinis dan reflektif
b. Mampu melakukan deteksi dini, konsultasi, kolaborasi dan rujukan,
didukung kemampuan berpikir kritis dan rasionalissi klinis sesuai lingkup
asuhan reproduksi.
c. Mampu melakukan KIE, promosi kesehatan dan konseling tentang
kesehatan reproduksi
d. Mampu melakukan pendokumentasian asuhan dan pelaporan pelayanan
kebidanan sesuai kode etik profesi (pranikah dan prakonsepsi)
e. Mampu melakukan KIE, promosi kesehatan dan konseling tentang
kesehatan reproduksi, kehidupan berkeluarga sehat antara lain; perilaku
reproduksi sehat, perencaan keluarga, persiapan menjadi orang tua,
pemunahan hak asasi manusia, keadilan dan kesetaraan gender
f. Mampu melakukan upaya pemberdayaan perempuan sebagai mitra untuk
meningkatkan kesehatan perempuan
g. Mampu membuat keputusan secara tepat dalam pelayanan kebidanan
berdasarkan pemikiran logis, kritis, inovatif sesuai dengan kode etik
1. Konseling pranikah
ii
3. Melakukan skrining HIV pranikah / pre marital check up
6. Imunisasi pranikah
9. Kolaborasi dan atau rujukan secara tepat pada wanita atau ibu
dengan gangguan sistem reproduksi
D. TARGET
1. CBD 1
2. BST 2
3. Refleksi Kasus 1
4. Journal Reading 2
5. OMP 1
iii
iv
v
LAPORAN CASE BASED DISCUSSION (CBD)
STASE PRANIKAH PRAKONSEPSI
ASUHAN KEBIDANAN PADA NN N DENGAN AMENOREA SEKUNDER
TAHUN AKADEMIK 2022/2023
Disusun Oleh :
MARWAH JAMALUDDIN
202210091
vi
HALAMAN PENGESAHAN LAPORAN CASE BASED DISCUSSION (CBD)
vii
DAFTAR ISI
DAFTAR ISI............................................................................................. i
PENDAHULUAN...................................................................................... 2
1. Latar Belakang .............................................................................................. 2
2. Tujuan ........................................................................................................... 3
TINJAUAN TEORI........ 5
A. KONSEP DASAR TENTANG KESEHATAN REPRODUKSI .................... 5
PEMBAHASAN ......................................................................................15
KESIMPULAN....................................................................................... 16
REFERENSI......................................................................................... 17
i
PENDAHULUAN
1. Latar Belakang
menurut WHO adalah kesejahteraan fisik, mental dan sosial yang utuh
bukan hanya bebas dari penyakit atau kecacatan dalam segala aspek
mahal. Ada juga yang tidak mempedulikan gejala yang muncul, dan
menstruasi menjadi lebih lama dan atau banyak, tidak teratur, lebih
sering atau tidak menstruasi sama sekali, bahkan bisa disertai nyeri.
selama masa hidupnya. Gangguan ini dapat berupa kelainan siklus atau
2
klimakterium (Kumalasari dan Andhyantoro, 2013)
tumor, penyakit infeksi, stres (di rumah, sekolah, atau tempat kerja),
latihan fisik yang melelahkan, dan gangguan gizi dimana berat badan
yang sehat dan tenang, mengurangi berat badan pada wanita dengan
obesitas, olah raga, dan konsumsi nutrisi yang seimbang. Selain itu
(Merin, 2013)
2. Tujuan
a. Tujuan Khusus
3
b. Tujuan Umum
4
TINJAUAN TEORI
1. Defenisi
hasil akhir keadaan sehat sejahtera secara fisik, mental dan sosial dan
tidak hanya bebars dari penyakit atau kecacatan dalam segala hal
Wilujeng, 2014).
5
1) Amenore merupakan perubahan umum yang
kram.
menstruasi.
pramenstruasi
1. Defenisi
6
atau Jing-Bi adalah keadaan tidak haid untuk sedikitnya 3 bulan
2. Etiologi
reproduksi lainnya
3. Gejala
7
serta perubahan bentuk tubuh. Jika penyebabnya adalah kehamilan
adalah denyut jantung yang cepat, kecemasan, kulit yang hangat dan
perut buncit dan lengan serta tungkai yang kurus. Gejala lain yang
a. Sakit kepala
ukuran payuarabenar.
4. Diagnosa
a. Biopsi endometrium
b. Progestin withdrawal
c. Kadar prolaktin
d. Kadar hormon
8
f. Tes kehamilan
5. Penatalaksanaan
menjalani diet yang tepat. Jika penyebannya adalah olah raga yang
9
ditangani dengan Kombinasi terapi akupunktur dengan prinsip
Zhongji (CV 3), Diji (SP 8), Hegu (LI 4), Sanyinjiao (SP 6),
Taichong (LV 3), Fenglong (ST 40), dan Guanyuan (CV 4). Selain
itu, pasien juga mendapat terapi herbal yaitu kunyit yang memiliki
dengan dosis kunyit sebanyak 21 gr, asam kawak 5 gr, madu 3 sdm,
mL
estrogenik.
10
DOKUMENTASI SOAP DAN RENCANA TINDAK LANJUT
No. RM : 2X XX XX
1. Nama Istri : NN N
2. Umur : 21 Tahun
3. Suku : Bugis
4. Agama : Islam
5. Pendidikan: SMA
6. Pekerjaan : Wiraswasta
7. Alamat : Pangkajene
a. Subjecktif ( S )
menstruasi
11
- Nn. N mengatakan menstruasinya 5 – 6 hari
menstruasi
b. Objecktif ( O)
- Kesadaran :Composmentis
- TTV :
- TD : 110/70 mmHg
- R: 20x/menit
- N : 78 x/menit
- S : 36,40 C
- TB : 157 cm
sklera
putih.
tanggal
12
dan tidak ada caries gigi.
tidak edema
c. Analisa( A )
d. Penatalaksanaan ( P )
amenorea sekunder
makanan bergizi
13
- Berikan support mental pada pasien untuk mengurangi kecemasan
kecemasannya
- Anjurkan pasien untuk kunjungan ulang 10 hari lagi atau jika ada
keluhan.
14
PEMBAHASAN
selanjutnya berhenti lebih dari tiga bulan . Amenore sekunder atau Jing-
15
KESIMPULAN
penyakit infeksi, stres (di rumah, sekolah, atau tempat kerja), latihan fisik
yang melelahkan, dan gangguan gizi dimana berat badan rendah untuk
lingkungan yang sehat dan tenang, mengurangi berat badan pada wanita
dengan obesitas, olah raga, dan konsumsi nutrisi yang seimbang. Selain itu
16
REFERENSI
17
18
19
20
21
22
23
REFLEKSI KASUS
1. DESKRIPSI KASUS
Pada tanggal 19 januari 2023, Nona N datang Ke puskesmas di antar oleh
ibunya. Nn. N mengatakan bahwa sampai saat ini dirinya belum pernah
menstruasi. Nn N mengeluh cemas dengan keadaannya Nn. N mengatakan
belum pernah menikah . Dari hasil pemeriksaan didapatkan keadaan umum :
baik kesadaran :composmentis TTV TD : 100/70 mmHg R: 20x/menit N
: 80 x/menit S : 36,40 C TB: 157 cm BB :42 kg LILA :22 cm dan
Pemeriksaan head to toe dalam batas normal
2. EMOSI PRIBADI
Pada saat saya melihat nonaN, saya menydari nona N terlihat cemas dan
bingug dengan kondisi kesehatan reproduksinya saat ini. Perasaan pertama
setelah melihat nona N adalah kasian dan berempati dan mendoakan
kesehatan reproduksi nona K dapat normal
3. EVALUASI
Apa yang menyebabkan terjadinya amenorea primer ? Bagaimana asuhan
kebidanan dalam kasus amenorea primer ?
4. ANALISA KASUS
Sama halnya dengan amenorea sekunder, pada amenorea primer ada
banyak faktor penyebab terjadinya amenorea sekunder diantaranya
penyebabnya kemungkinan gangguan gizi dan metabolisme, gangguan
hormonal, terdapat tumor alat kelamin atau terdapat penyakit menahun.
Penyebab amenore diakibatkan oleh beberapa keadaan seperti hipotensi,
anemia, infeksi, atau kelemahan kondisi tubuh secara umum. Selain itu bisa
juga disebabkan oleh stres psikologis.
Pada kasus amenorea primer , asuhan kebidanan yang dapat dilakukan
ialah pemeberian konseling mengenai mengenai amenore primer, anjurkan
pasien untuk istirahat yang cukup dan mengkonsumsi makanan bergizi,
berikan support mental pada pasien untuk mengurangi kecemasan. Terapi
selanjutnya merupakan wewenang dokter spesialis obgyn
24
5. KESIMPULAN
Dalam masa kanak-kanak ovarium boleh dikatakan masih dalam keadaan
istirahat, belum menunaikan faalnya dengan baik. Baru jika terjadi pubertas (
akil balig), maka terjadilah perubahan-perubahan dalam ovarium yang
mengakibatkan pula perubahan-perubahan besar pada seluruh badan wanita
tersebut. Pubertas tercapai pada umur 12-16 tahun dan dipengaruhi oleh
keturunan, bangsa, iklim, dan lingkungan. Kejadian yang terpenting dalam
pubertas ialah timbulnya haid yang pertama kali (menarche ). Walaupun
begitu menarche merupakan gejala pubertas yang lambat. Paling awal terjadi
pertumbuhan payudara ( thelarche ), kemudian tumbuh rambut kemaluan (
pubarche ), disusul dengan tumbuhnya rambut di ketiak. Setelah tu barulah
terjadi menarche, dan sesudah itu haid datang secara siklik.
Haid ( menstruasi ) adalah perdarahan yang siklik dari uterus sebagai
tanda bahwa alat kandungan menunaikan faalnya. Secara fisiologis
menstruasi adalah proses hormonal dalam tubuh wanita sebagai hasil dari
pelepasan ovum. Pelepasan itu terjadi ketika ovum yang ada di ovarium tidak
dibuahi. Amenore adalah absennya perdarahan menstruasi. Amenore normal
terjadi pada wanita prepubertal, kehamilan, dan postmenopause. Pada wanita
usia reproduktif, yang harus diperhatikan pertama kali dalam mendiagnosa
etiologi dari amenore adalah kehamilan. Apabila tidak ada kehamilan, barulah
kita harus mencari alternatif lain untuk mencari etiologi dari amenore itu
sendiri kehidupan
Menurut Nugroho dan Utama (2014), pengobatan tergantung kepada
penyebabnya. Jika penyebabnya adalah penurunan berat badan yang drastis
atau obesitas, penderita dianjurkan untuk menjalani diet yang tepat. Jika
penyebannya adalah olah raga yang berlebihan, penderita dianjurkan untuk
menguranginya. Jika seorang anak perempuan belum pernah mengalami
menstruasi dan semua hasil pemeriksaan normal, maka dilakukan
pemeriksaan setiap 3 – 6 bulan untuk memantau perkembangan pubertasnya.
Untuk merangsang menstruasi bisa diberikan progesteron. Untuk merangsan
perubahan pubertas pada anak perempuan yang payudaranya belum
membesar atau rambut kemaluan dan ketiaknya belum tumbuh bisa diberikan
25
estrogen
6. TINDAK LANJUT
Pada kasus Nona K , tindakan yang dilaksanakan ialah jelaskan pada pasien
tentang hasil pemeriksaan, berikan kie pada pasien mengenai amenore primer
, anjurkan pasien untuk istirahat yang cukup dan mengkonsumsi makanan
bergizi , berikan support mental pada pasien untuk mengurangi kecemasan
dan anjurkan nona K untuk langsung berkonsultasi dengan dokter spesialis
obgyn
26
LAPORAN PRAKTIK PROFESI READING JURNAL
TENTANG HUBUNGAN KONSELING NUTRISI DENGAN
KECEMASAN PASIEN AMENOREA PRIMER
TAHUN AKADEMIK 2023
Disusun Oleh :
MARWAH JAMALUDDIN
202210091
27
HALAMAN PENGESAHAN READING JURNAL
TENTANG HUBUNGAN KONSELING NUTRISI DENGAN
KECEMASAN PASIEN AMENOREA PRIMER
TAHUN AKADEMIK 2023
B. Skala
Amenorea primer pada remaja yang tidak ditangani dengan tepat akan
menimbulkan berbagai masalah kesehatan reproduksi diantaranya ialah
infertilitas.
C. Kronologi
Penyebab Amenorea primer merupakan suatu kejadian yang tidak
pernah mengalami menstruasi samasekali, Amenore primer juga dapat
diakibatkan oleh kelainan pada aksis hipotalamus-hipofisis-ovarium.
Hypogonadotropic amenorrhoea menunjukkan keadaan dimana terdapat
sedikit sekali kadar FSH dan SH dalam serum. Akibatnya, ketidakadekuatan
hormon ini menyebabkan kegagalan stimulus terhadap ovarium untuk
melepaskan estrogen dan progesteron. Kegagalan pembentukan estrogen dan
progesteron akan menyebabkan tidak menebalnya endometrium karena tidak
ada yang merasang. Terjadilah amenore. Hal ini adalah tipe keterlambatan
pubertas karena disfungsi hipotalamus atau hipofosis anterior, seperti
adenoma pitiutari (Merin dkk, 2012).
Menurut Manuaba (2013), penyebabnya kemungkinan gangguan gizi
dan metabolisme, gangguan hormonal, terdapat tumor alat kelamin atau
terdapat penyakit menahun. Penyebab amenore diakibatkan oleh beberapa
keadaan seperti hipotensi, anemia, infeksi, atau kelemahan kondisi tubuh
secara umum. Selain itu bisa juga disebabkan oleh stres psikologis
Pada pasien yang mengalami amenorea akan muncul berbagai
masalah gangguan psikologi salah satunya ialah kecemasan, kecemasan yang
berlebihan akan menambah masalah pada kelenjar hipofisis dan membuat
amenorea primer makin sulit untuk diidentifikasi.
D. Solusi
dipicu oleh masalah nutrisi pada remaja seperti anemia, gaya hidup tidak
yang terjadi pada diri remaja perlu untuk disosialisasikan agar remaja yang
BAB II
TINJAUAN PUSTAKA
A. Asuhan Kebidanan
1. Hasil penelitian ini diharapkan dapat menjadi referensi dalam pemberian asuhan kebidanan
dengan kasus amenorea primer di RSUD Ponek
2. Hasil penelitian ini diharapkan dapat menjadi kebutuhan untuk penelitian lebih lanjut
mengenai amenorea primer
DAFTAR PUSTAKA
Disusun Oleh :
MARWAH JAMALUDDIN
202210091
i
KATA PENGANTAR
ii
DAFTAR ISI
iii
BAB I
PENDAHULUAN
E. Masalah
Amenore sekunder lebih menunjuk kepada sebab yang timbul kemudian dalam
kehidupan wanita, salah satunya ialah stres (di rumah, sekolah, atau tempat kerja
Wanita dalam kehidupannya tidak luput dari adanya siklus menstruasi normal yang
terjadi secara periodik. wanita akan merasa terganggu bila hidupnya mengalami
perubahan, terutama bila menstruasi menjadi lebih lama dan atau banyak, tidak
teratur, lebih sering atau tidak menstruasi sama sekali, bahkan bisa disertai nyeri.
Diharapkan semua wanita mengalami siklus menstruasi yang teratur, namun hampir
semua wanita pernah mengalami gangguan menstruasi selama masa hidupnya.
Gangguan ini dapat berupa kelainan siklus atau perdarahan. Masalah ini dihadapi
oleh wanita remaja, reproduksi dan klimakterium (Merin, 2013)
Kesehatan reproduksi merupakan aspek yang menjadi perhatian setelah upaya
kesehatan pada umumnya tercapai. Kesehatan reproduksi menurut WHO adalah
kesejahteraan fisik, mental dan sosial yang utuh bukan hanya bebas dari penyakit
atau kecacatan dalam segala aspek yang berhubungan dengan sistem reproduksi,
fungsi serta prosesnya (Manuaba, I.B.G. 2013)
Wanita rentan terhadap penyakit yang menyerang organ reproduksinya.
Kebanyakan wanita, sangat malu dan tertutup untuk berkonsultasi secara langsung
mengenai kesehatan pribadinya. Faktor lain pun dikarenakan biaya untuk
pemeriksaan ke dokter spesialis cenderung mahal. Ada juga yang tidak
mempedulikan gejala yang muncul, dan ketika kondisi sudah memburuk dan
memerlukan penanganan yang ekstra, dokter spesialis menjadi tujuan akhir (Merin,
2013)
F. Skala
Gangguan amenorea sekunder dapat dialami oleh remaja hingga dewasa.
Namun pada usia remaj hingga pranikah pada umumnya amenorea sekunder terjadi
sebabkan oleh stress yang mempengaruhi hipotalamus untuk tidak mematangkan
sel ovum. Kondisi ini menyebabkan komplikasi terparah jika kasus amenorea
sekunder tidak segera diatasi ialah infertilitas.(Merin, 2013)
G. Kronologi
Menurut Fansia (2013), penyebab amenore sekunder dapat fisiologik,
endokrinologik, atau organik, atau akibat gangguan perkembangan. Amenore dalam
ilmu TCM (Traditional Chinese Medicine) disebut sebagai Jing-Bi disebabkan
karena keadaan emosional (stress), hormonal, perubahan lingkungan, dan beberapa
penyakit organ reproduksi lainnya
Sedangkan menurut Manuaba (2013), penyebabnya kemungkinan gangguan
hormonal, terdapat tumor alat kelamin atau terdapat penyakit menahun. Penyebab
amenore diakibatkan oleh beberapa keadaan seperti hipotensi, anemia, infeksi, atau
kelemahan kondisi tubuh secara umum. Selain itu bisa juga disebabkan oleh stres
psikologishiperemesis gravidarum belum diketahui secara pasti. Resiko
kemandulan dan komplikasi kesehatan reproduksi merupakan resiko masalah
kesehatan yang akan terjadi jika tidak mendapatkan penanganan yang cepat dan
tepat.
H. Solusi
Penangan yang dapat dilakukan bidan sesuai evidance based midwifery dalam
mengatasi masalah amenorea sekunder adalah pemberian konseling edukasi dan
informasi mengenai amenorea sekunder dan manajemen stress agar pasien tidak
mengalami kecemasan yang berlebihan.
BAB II
TINJAUAN PUSTAKA
E. Asuhan Kebidanan
P:
- Jelaskan pada pasien
tentang hasil
pemeriksaan
Hasil : Nn J telah mengetahui
kondisi kesehatannya saat ini
- Berikan KIE pada
pasien mengenai
amenore sekunder
Hasil : Nn J sudah mendapatkan
konseling dan edukasi
mengenai amenorea sekunder
- Anjurkan pasien untuk
istirahat yang cukup dan
mengkonsumsi makanan
bergizi
Hasil : Nn J sudah dianjurkan
untuk istrirahat yang cukup dan
mengkonsumsi makanan yang
bergizi
- Berikan support mental
berupa management
stress pada pasien untuk
mengurangi kecemasan
Hasil : Nn J telah diberikan
support mental untuk
mengurangi kecemasannya
- Anjurkan pasien untuk
memeriksakan dirinya
ke Dokter Spesialis
Obgyn
Hasil : Nn J mengatakan akan
berkonsultasi dengan dokter
spesialis obgyn
F. Telaah Jurnal
Jurnal Judul Populasi Intervensi Comparasio Outcome Time
Sports Med Manajemen stress Wanita usia - Pemberian Pada asuhan kebidanan - Kecemasa 1 hari
2021; 31 dengan 18-21 konseling informasi yang telah saya lakukan n pasien amenorea
(15): 1025- kecemasan pasien tahun yang edukasi mengenai dengan kasus amenorea sekunder menurun
1031 amenorea belum manajemen stress agar sekunder tidak ada
sekunder pernah tidak mempengaruhi kesenjangan antara
menikah kinerja hipotalamus asuhan kebidanan yang
sebanyak dalam merangsang telah diberikan dengan
45 orang pematangan ovum intervensi yang
- Faktor tercantum pada jurnal ini
prognostik dalam
penelitian ini ialah :
penyakit infeksi dan
gangguan metabolisme
Current Manajemen stress Wanita usia - Pemberian Pada asuhan kebidanan - Amenorea 1 hari
Opinion in dengan amenorea 18-21 konseling informasi yang telah saya lakukan sekunder teratasi
Psycofarm sekunder pada tahun yang edukasi mengenai dengan kasus amenorea dengan manajemen
2022Vol 6 gadis muda belum manajemen stress agar sekunder tidak ada stress
No 7 pernah tidak mempengaruhi kesenjangan antara
menikah kinerja hipotalamus asuhan kebidanan yang
sebanyak dalam merangsang telah diberikan dengan
28 orang pematangan ovum intervensi yang
- Faktor tercantum pada jurnal ini
prognostik dalam
penelitian ini ialah :
penyakit infeksi
Clin Res Pengaruh Wanita usia - mempengaruhi Pada asuhan kebidanan - Kecemasa 2 hari
Pediatr manajemen stress 18-21 kinerja hipotalamus yang telah saya lakukan n pasien amenorea
Endocrinol terhadap tahun yang dalam merangsang dengan kasus amenorea sekunder menurun
2020;12(Su kecemasan pasien belum pematangan ovum sekunder tidak ada
ppl 1):18-27 amenorea pernah - Faktor kesenjangan antara
sekunder menikah prognostik dalam asuhan kebidanan yang
sebanyak penelitian ini ialah : telah diberikan dengan
45 orang penyakit infeksi intervensi yang
tercantum pada jurnal ini
G. Deskripsi Asuhan Kebidanan dengan Reading Jurnal
Hasil asuhan kebidanan yang saya lakukan kepada pada Nn J usia 21 tahun dengan
amenorea sekunder sejalan dengan hasil reading jurnal pertama yang diteliti oleh (David C.
Cumming, 2021) dalam jurnal Sports Med 2021; 31 (15): 1025-1031 dengan judul Manajemen
stress dengan kecemasan pasien amenorea sekunder, dimana hasil penelitian ini manajemen
stress mempengaruhi kecemasan pasien amenorea sekunder dengan tingkat signifikasi P
<0.005 kemudian didukung oleh jurnal kedua yang diteliti oleh ( Blazej Meczekalski, 2022)
dalam jurnal Current Opinion in Psycofarm 2022 Vol 6 No 7 dengan judul Manajemen stress
dengan amenorea sekunder pada gadis muda hasil penelitian menyatakan manajemen stress
mempengaruhi kecemasan pasien amenorea sekunder dengan tingkat signifikasi P = 0.001
Kemudian disertai oleh jurnal ketiga yang diteliti oleh (Marie Eve Sophie Gibson, 2020) dalam
jurnal Clin Res Pediatr Endocrinol 2020;12(Suppl 1):18-27 dengan judul Pengaruh manajemen
stress terhadap kecemasan pasien amenorea sekunder hasil penelitian menyatakan manajemen
stress mempengaruhi kecemasan pasien amenorea sekunder dengan tingkat signifikasi P
<0.005
H. Teori dari pokok bahasan asuhan kebidanan dengan reading jurnal
Teori dari pokok bahasan asuhan kebidanan dengan reading jurnal ialah manajemen stress
yang dapat mempengaruhi kerja hipotalamus dalam merangsang pematang sel telur pada
wanita. Dalam asuhan kebidanan pranikah ini dukungan mental dan spiritual merupakan salah
satu bagian dari manajemen stress dimana individu menyerahkan dirinya kepada sang pencipta.
Stress manajemen dapat berupa dukungan menta dan spiritual dimana pada setiap
pemberian konseling informasi dan edukasi peran tenaga kesehatan diantaranya ialah
memberikan dukungan mental dan spiritual agar pasien tidak mengalami kecemasan yang
berlebihan terhadap penyakitnya
Hal ini sejalan dengan penelitian terdahulu yang dilakukan oleh (Septia, 2014) bahwa
manajemen stress dapat mengurangi tingkat kecemasan pasien serta dapat membuat pasien
lebih nyaman sehingga penyakit dapat segera teratasi. penelitian ini menunjukan bahwa ada
hubungan yang signifikan antara stress manajemen dengan tingkat kecemasan pasien. Semakin
pasien mengetahui tentang stress manajemen maka tingkat kecemasan terhadap suatu penyakit
akan menurun
Teori ini juga didukung oleh ( Alexandre, 2013) bahwa psikologis seorang individu akan
mempengaruhi status kesehatannya, seperti amenorea sekunder yang dapat terjadi karena stress
yang berlebihan hingga mempengaruhi hipotalamus dalam merangsang pematangan sel telur
1
0
Dan pada jurnal 1,2,3 terkait dengan kasus menjelaskan tidak ada perbedaan secara signifikan
dalam pemberian asuhan kebidanan pada kasus amenorea sekunder
1
1
BAB III
KESIMPULAN DAN SARAN
C. KESIMPULAN
Dari pembuatan jurnal reading ini dapat disimpulkan bahwa tidak ada kesenjangan antara
asuhan kebidanan yang saya berikan kepada Nn J Usia 21 Tahun dengan Amenorea Sekunder
dengan jurnal 1,2,3 dan dengan teori evidance based yang ada
Stress manajemen dapat berupa dukungan menta dan spiritual dimana pada setiap
pemberian konseling informasi dan edukasi peran tenaga kesehatan diantaranya ialah
memberikan dukungan mental dan spiritual agar pasien tidak mengalami kecemasan yang
berlebihan terhadap penyakitnya
Kesehatan reproduksi merupakan aspek yang menjadi perhatian setelah upaya kesehatan
pada umumnya tercapai. Kesehatan reproduksi menurut WHO adalah kesejahteraan fisik,
mental dan sosial yang utuh bukan hanya bebas dari penyakit atau kecacatan dalam segala
aspek yang berhubungan dengan sistem reproduksi, fungsi serta prosesnya. Wanita rentan
terhadap penyakit yang menyerang organ reproduksinya. Kebanyakan wanita, sangat malu dan
tertutup untuk berkonsultasi secara langsung mengenai kesehatan pribadinya. Faktor lain pun
dikarenakan biaya untuk pemeriksaan ke dokter spesialis cenderung mahal. Ada juga yang
tidak mempedulikan gejala yang muncul, dan ketika kondisi sudah memburuk dan memerlukan
penanganan yang ekstra, dokter spesialis menjadi tujuan akhir
D. SARAN
3. Hasil penelitian ini diharapkan dapat menjadi referensi dalam pemberian asuhan kebidanan
dengan kasus amenorea sekunder di RSUD Ponek
4. Hasil penelitian ini diharapkan dapat menjadi kebutuhan untuk penelitian lebih lanjut
mengenai amenorea sekunder
1
2
DAFTAR PUSTAKA
Bartini. (2019). Buku Ajar Asuhan Kebidanan Kehamilan. EGC.
Kumalasari dan Andhyantoro, 2013. Kesehatan Reproduksi untuk Mahasiswa Kebidanan dan
Keperawatan. Jakarta: Salemba Medika
Manuaba, I.B.G. 2013 Memahami Kesehatan Reproduksi Wanita. Jakarta : EGC
Merin,2013. Amenorrhea: Cytogenetic Studies and Beyond.
core.ac.uk/download/pdf/12348799.pdf. diakses 14 februari 2023
1
3
Format OMP ( One Minute Preceptor)
O: TTV
TD : 100/70mmhg
N: 80 X/M
S : 36
R : 20 X/M
2 Get a Commitment
Diagnosis : amenore
Tanyakan komitmen mahasiswa
terkait dengan hasil pemeriksaan
Diagosis Banding:
pada Kasus
Pemeriksaan penunjang :
Terapi :
Dll:
1
4
Katakana apa yang dilakukan
mahasiswa sudah benar
5 Help Learner identify and give Evaluasi
1. Meminta
guidance about emissions and
mahasiswa
errors mengevaluasi
kesalahan/kekuran
gan yang telah
Perbaiki kesalahan mahasiswa dilakukan)
Hasil mahasiswa sudah
yang berulang
mampu melakukan
tindakan sesuai daftar
tilik
2. Saran Perbaikan
keterampilan oleh
pembimbing untuk
Mahasiswa
Hasil tetap di
pertahankan dan
tingkatkan
1
5
Format Laporan Target Kompetensi (LogBook ASKEB)
Nama Mahasiswa: Marwah Jamaluddin
Asuhan Kebidanan Pra Konsepsi pada Nn N dengan Amenore sakunder di UPT Puskesmas Pangkajene
Deskripsi Kegiatan Responsi Pembimbing CI TTD
Tanggal: Subjektif
19/01/23 1. Ibu mengatakan Mahasiswa
ingin
memeriksakan
No RM: 1x Xx keadaannya
Xx 2. Mengatakan tidak
menstruasi
selama 3 bulan Marwah jamaluddin
Identitas Pasien:
Nama Nn
Nurlina
Objektif
TTV
Umur 19 THN
TD100/70mmhg
N: 80 X/M
Agama Islam S : 36
R : 20 X/M CI Institusi:
Suku Bugis
Pendidikan
SMP Analisa Amenore
Primer
Pekerjaan -
Nasrayanti,S.ST.,M.Keb
Alamat Penatalaksanaan
pangkajene 1. Beritahu
hasil
pemeriksaan
pada pasien
No.Hp Pembimbing lahan
2. Kie tentang
085 XXX XXX amenore
XX primer
Herlina, S.ST
1
6
Format Laporan Target Kompetensi (LogBook ASKEB)
Nama Mahasiswa: Marwah Jamaluddin
Asuhan Kebidanan Pra Konsepsi pada Nn H dengan Amenore sakunder di UPT Puskesmas Pangkajene
Deskripsi Kegiatan Responsi Pembimbing CI TTD
Tanggal: Subjektif Mahasiswa
19/01/23 3. Ibu mengatakan
ingin
memeriksakan
No RM: 1x Xx keadaannya
Xx 4. Mengatakan tidak
menstruasi Marwah jamaluddin
selama 3 bulan
Identitas Pasien:
Nama Nn
Herunisa
Objektif
TTV
Umur 20 THN
TD100/70mmhg
N: 80 X/M
Agama Islam S : 36 CI Institusi:
R : 20 X/M
Suku Bugis
Pendidikan
SMP Analisa Amenore
sakunder
Pekerjaan -
Nasrayanti,S.ST.,M.Keb
Herlina, S.ST
1
7
TATA TERTIB MAHASISWA DI LAHAN PRAKTIK
ITKES MUHAMMADIYAH SIDRAP
A. Sikap
1. Disiplin dalam tugas
2. Kerja sama dengan orang lain sesuai dengan ketentuan institusi
3. Inisiatif dalam bekerja
4. Bertanggung jawab dalam tugas yang diberikan
5. Komunikasi yang baik dengan klien
6. Perhatian dalam bekerja
7. Jujur, sopan dan teliti dalam bekerja
B. Waktu kehadiran
1. Jam 07.30 sampai 14.00 WITA untuk dinas pagi
2. Jam 14.00 sampai 21.00 WITA untuk dinas sore
3. Jam 21.00 sampai 07.30 WITA untuk dinas malam
C. Tidak diperkenankan meninggalkan ruangan tempat praktik tanpa seizin kepala
ruangan/pembimbing atau petugas ruangan serta tidak diperkenankan meninggalkan
lokasi/wilayah praktik klinik tanpa seizin C.I institusi
D. Sanksi penggantian dinas praktik diberikan kepada mahasiswa apabila (disesuaikan oleh
lahan) :
1. Izin 1 hari ganti dinas 1 hari
2. Sakit 1 hari ganti dinas 1 hari (harus ada surat keterangan Dokter)
3. Alpa 1 hari ganti dinas 2 hari
4. Bila mahasiswa merusak, menghilangkan alat-alat di ruangan praktik berkewajiban
mengganti alat tersebut
5. Mahasiswa berkewajiban menjaga kebersihan dan kesterilan alat-alat dan bahan praktik
yang dimiliki di lahan praktik
6. Tidak diperkenankan menggunakan alat-alat dan bahan praktik milik lahan praktik, milik
klien dan atau memindahkan tanpa sepengetahuan kepala ruangan
7. Mahasiswa baik secara pribadi atau kelompok berkewajiban mengganti alat-alat, bahan-
bahan praktik yang hilang atau rusak selama praktik
1
8
8. Mahasiswa hendaknya membawa sendiri alat-alat pemeriksaan fisik
1
9
DAFTAR TILIK ASUHAN KEBIDANAN PADA PRANIKAH DAN
PRAKONSEPSI
2
0
DAFTAR ISI
HALAMAN JUDUL
DAFTAR ISI...................................................................................................... 2
JENIS KETERAMPILAN BIMBINGAN BST................................................. 3
KETERAMPILAN KONSELING PERSIAPAN KEHAMILAN SEHAT.....................4
ANAMNESA PRANIKAH DAN PRAKONSEPSI............................................................6
KETERAMPILAN KIE PERSIAPAN MENJADI ORANG TUA.................................12
CHEKLIST PENILAIAN SKRINING HIV......................................................................14
KETERAMPILAN MELAKUKAN SKRINNING CA CERVIX DENGAN IVA.........15
KETERAMPILAN MENYIAPKAN SEDIAAN PEMERIKSAAN PAPSMEAR.........18
2
1
JENIS KETERAMPILAN BIMBINGAN BED SIDE TEACHING (BST)
mahasiswa.
Kompetensi kemampuan ketrampilan mahasiswa dilakukan melalui bedside teaching yang
dilakukan secara bertahap mulai dari tahap observasi, di bantu hingga mandiri.
Bedside teaching (BST) adalah suatu proses pembelajaran dimana mahasiswa
berinteraksi langsung dengan pasien sesungguhnya dan dibawah bimbingan preseptor.
BST merupakan pembelajaran yang aktif melibatkan pasien langsung sehingga
mahasiswa dapat belajar dari kasus nyata yang sangat beraneka ragam tingkat kompleksitas
kasus yang dialami pasien.
BST melibatkan preseptor dan mahasiswa dengan pasien langsung yang bertujuan untuk melakukan asuha
mahasiswa, ketrampilan komunikasi dan juga ketrampilan berfikir klinis karena dengan BST
mahasiswa menggunakan semua indera yang dimiliki saat praktek di depan pasien langsung
sehingga dapat mendukung ketrampilan mahasiswa, dengan praktek langsung di depan pasien
tidak hanya meningkatkan ketrampilan namun juga mampu meningkatkan komunikasi,
meningkatkan rasa empati dan simpati ke pasien.
Setiap keterampilan dilakukan tiga kali BST dengan model sitting in as observer (mahasiswa
hanya mengobservai), three ways consultation (mahasiswa melakukan bersama-sama dengan
pembimbing) dan hot seating (mahasiswa melakukan sepeneuhnya dengan diawasi
pembimbing).
Penentuan jumlah/ frekuensi BST disesuaikan dengan tingkat penyerapan masing-masing mahasiswasampai m
Mahasiswa yang telah menempuh bedside teaching sampai tahap mandiri dilakukan
asessment menggunakan DOPS (Direct Observation Procedural Skill) atau Mini-CEX (Mini
Clinical Examination).
Jenis Keterampilan Bimbingan Bed Side Teaching (BST) Statse Asuhan Kebidanan Pada
Pranikah dan Prakonsepsi dapat dipilih mahasiswa pada kolom BST, Target BST untuk states
tersebut adalah 2 sehingga masing-masing mahasiswa memilih 2 diantara beberapa
keterampilan yang telah disediakan dengan mengacu pada daftar tilik yang ada.
22
PERSIAPAN KEHAMILAN SEHAT
STANDAR OPERATING PROSEDUR
23
10. Menjelaskan mengenai hepatitis B dan upaya
pencegahan pada catin
11. Menjelaskan mengenai diabetes melitus dan resikonya
12. Menjelaskan mengenai malaria dan dampaknya bagi catin
13. Menjelaskan mengenai TORCH dan dampaknya bagicatin
14. Menjelaskan mengenai thalasemia dan dampaknya padacatin
15. Menjelaskan mengenai pencegahan thalasemia bagi catin
16. Menjelaskan mengenai hemofilia dan dampaknya padacatin
17. Menjelaskan mengenai pencegahan hemofilia pada catin
24
CEKLIS PERSIAPAN KEHAMILAN SEHAT
Petunjuk penilaian :
0 = tidak dilakukan
1 = dilakukan tidak sempurna
2 = dilakukan dengan sempurna
25
20 Menjelaskan mengenai pencegahan hemofilia pada
Catin
Score : 30
C TEKNIK
21 Teruji melaksanakan secara sistematis
22 Teruji menggunakan bahasa yang mudah dimengerti
23 Teruji memberikan perhatian terhadap respon pasien
24 Teruji melaksanakan dengan percaya diri dan tidak
ragu-ragu
25 Teruji mendokumentasikan hasil
Score : 10
Total Score : 50
CI lahan
( Herlina, S.ST)
26
ANAMNESA PRANIKAH DAN PRAKONSEPSI
27
Langkah-langkah 1. Menjelaskan tujuan anamnesa pada calon pengantin/calonibu
2. Melakukan anamnesa pada ibu meliputi :
a. Menanyakan identitas pasien dan suami
b. Menanyakan keluhan pada ibu
c. Menanyakan apakah ini perencanaan kehamilan yang
pertama/pernikahan yang pertama
d. Mengkaji ulang atau menanyakan mengenai riwayat
kehamilan terdahulu tentang paritas
e. Mengkaji riwayat kontrasepsi
f. Mengkaji ulang dan menanyakan mengenai menstruasi meliputi
HPHT dan masalah seputar menstruasi dan keputihan
g. Mengkaji riwayat penyakit seperti DM, asma, hipertensi,
Jantung
28
h. Mengkaji penyakit genetik pada keluarga ibu maupunsuami
seperti thalasemia,hemofilia, lupus
i. Mengkaji riwayat penyakit menular seperti hepatitis B,
TORCH, HIV atau IMS lainnya
j. Mengkaji pola nutrisi pada ibu
k. Mengkaji personal hygine pada ibu
l. Mengkaji kebiasaan mengkonsumsi minuman keras padaibu
maupun suami
m. Mengkaji kebiasaan merokok pada ibu maupun suami
n. Mengkaji penggunaan NAFZA pada ibu maupun suami
o. Mengkaji riwayat imunisasi TT pada ibu
p. Mengkaji upaya yang sudah dilakukan ibu dalam persiapan
pranikah dan prakonsepsi
Referensi 2. Kementerian Kesehatan Republik Indonesia. 2018. Kesehatan
Reproduksi Dan Seksual Bagi Calon Pengantin
29
CEKLIST ANAMNESA PRANIKAH/PRAKONSEPSI
Petunjuk penilaian :
0 = tidak dilakukan
1 = dilakukan tidak sempurna
2 = dilakukan dengan sempurna
30
25 Teruji melaksanakan dengan percaya diri dan tidak ragu-ragu
26 Teruji mendokumentasikan hasil
Score : 10
Total Score : 52
CI lahan
( Herlina, S.ST)
31
KIE PERSIAPAN MENJADI ORANG TUA
STANDAR OPERATING PROSEDUR
32
CEKLIST KIE PERSIAPAN MENJADI ORANGTUA
Petunjuk penilaian :
0 = tidak dilakukan
1 = dilakukan tidak sempurna
2 = dilakukan dengan sempurna
NO BUTIR YANG DINILAI NILAI
A SIKAP DAN PERILAKU 0 1 2
1 Menyambut pasien dengan sopan dan ramah
2 Memperkenalkan diri kepada pasien
3 Menjelaskan prosedur yang akan dilaksanakan
4 Menjaga privasi pasien
5 Tanggap terhadap reaksi pasien dan kontak mata
Score :10
B CONTENT/ISI
6 Menanyakan identitas pasien dan suami
7 Menanyakan alasan berkunjung
8 Menjelaskan tujuan KIE persiapan menjadi orang tua
Persiapan fisik
9 Memberikan KIE usia yang ideal untuk menjadi orangtua
10 Memberikan KIE persiapan gizi pada calon ayah maupun
calon ibu
11 Memberikan KIE persiapan imunisasi pada calon ibu
12 Memberikan KIE gaya hidup sehat pada calon orang tua
Persiapan mental
13 Memberikan KIE adaptasi psikologis pada kehamilan kepada
calon orangtua
Persiapan ekonomi
14 Menjelaskan hal-hal yang harus disiapkan berkaitan dengan ekonomi
sebagai persiapan menjadi orang tua meliputi kebutuhan saat hamil,
bersalin, imunisasi anak dan perawatan
Anak
Kesetaraan gender dalam persiapan menjadi orangtua
15 Memberikan KIE mengenai peran suami dan istri dalam
Keluarga
16 Memberikan KIE mengenai peran ayah dan ibu bagi anak
Score : 22
C TEKNIK
1 Teruji melaksanakan secara sistematis
2 Teruji menggunakan bahasa yang mudah dimengerti
3 Teruji memberikan perhatian terhadap respon pasien
4 Teruji melaksanakan dengan percaya diri dan tidak ragu-ragu
5 Teruji mendokumentasikan hasil
Score : 10
Total Score : 42
33
Nilai akhir = (Total score :42) x 100
CI lahan
( Herlina, S.ST)
34
LEMBAR CHEKLIST PENILAIAN
SKRINING HIV
1 2
NO BUTIR YANG DINILAI 0
10
Score : 30
C TEKNIK
Score : 4
Total Score : 34
CI lahan
( Herlina, S.ST)
36
STANDAR OPERATING PROSEDUR
1 2
NO BUTIR YANG DINILAI 0
C TEKNIK
Score : 4
Total Score : 58
CI lahan
41
( Herlina, S.ST)
MENYIAPKAN SEDIAAN PEMERIKSAAN PAPSMEAR
1 2
NO BUTIR YANG DINILAI 0
C TEKNIK
Score : 4
Total Score : 42
CI lahan
( Herlina, S.ST)
43
J. Endocrinol. Invest. 36: 343-346, 2013
DOI: 10.3275/8645
ABSTRACT. Background: Several studies have reported that professional and non-professional dancers than in controls.
low body weight and menstrual alterations are very frequent Frequency of menstrual dysfunction was 51%, 34% and 21%
findings in adolescent, suggesting they could be at risk for in professional dancers, non-professional dancers and con-
associated medical problems. However, it is still largely un- trols, respectively (p<0.0001). weight loss counseling and
known whether these alterations are also common in the very Anxienty in Primary Amenorrhea was reported by23% of
large number of young amateur dancers. Aim: The aim of this professional dancers, vs 1-7% in the other groups
study was to assess whether there is an increased prevalence (p<0.0001). Age at menarche occurred later in professional
of menstrual dysfunction also in amateur dancers. Materi- dancers than in the other groups. Logistic regression analy-
al/Subjects and Methods: Ninety-two professional ballet ses showed that menstrual dysfunction was associated with
dancers, 93 non-professional ballet dancers, and 293 (160 the training profile in professional dancers, and with BMI in
sedentary, 133 physically active) control women, ranging in non-professional dancers. Age at menarche was associated
age 14-23 yr, were included in the study. In these subjects, with menstrual dysfunction in both groups. Conclusions: This
a detailed questionnaire that included questions on weight, study shows that low body weight and menstrual dysfunc-
height, age at menarche, training profile and menstrual al- tion are frequent findings also in amateur ballet dancers.
terations was administered. Results: BMI was lower in both (J. Endocrinol. Invest. 36: 343-346, 2013)
©2013, Editrice Kurtis
343
E. Bacchi, G. Spiazzi, G. Zendrini, et al.
344
Low body weight and menstrual dysfunction in ballet dancers
Data are mean±SD, or percentage. ap=0.005-0.0001; bp=0.05-0.02 vs professional dancers; cp=0.05-0.02; dp=0.005-0.001 vs amateur dancers.
Table 3 - Predictors of menstrual dysfunction by logistic regression analysis, in professional and amateur dancers. Data are expressed
as mean and 95% confidence interval (CI). weight loss counseling and Anxienty in Primary Amenorrhea
Professional dancers group Amateur dancers group
OR (95% CI) p OR (95% CI) p
BMI (kg/m2) 0.96 (0.70-1.31) 0.80 0.61 (0.42-0.88) 0.008
Physical activity volume (h/day) 1.52 (1.06-2.20) 0.02 0.94 (0.56-1.57) 0.82
BMI: body mass index.
Logistic regression analysis showed that in professional sedentary controls vs 54% of athletes of different sports
ballet dancers menstrual dysfunction was independently had menstrual dysfunction (12). These figures are strik-
associated with the training profile, but not with the BMI, ingly similar to our findings in controls and elite dancers,
whereas in non-professional dancers it was independently respectively, suggesting reliable estimates of the preva-
associated with the BMI, but not with the training profile lence of menstrual dysfunction in our sample. However,
(Table 3). However, variance explained by the model was a slightly lower figure, 15%, was found in 900 unselected
low. BMI was associated with menstrual dysfunction al- college students referring to a student health centre, who
so in sedentary controls (data not shown), whereas no were submitted to a careful medical history (13).
variables predicted menstrual dysfunction in the physi- In elite dancers, menstrual dysfunction relies on functional
cally active non-dancer controls. hypothalamic abnormalities, due to low energy avail-
Age at menarche was associated, in all groups, with men- ability and low body fat (14). Although the pathogenesis
strual dysfunction. Odds ratios (95% CI) were 1.78 (1.28- of menstrual alterations was not investigated in the pre-
2.48) in professional dancers, 4.87 (2.26-10.51) in non- sent study, the hypothesis that it arises, for amateur
professional dancers, and 1.45 (1.13-1.85) in controls, re- dancers too, from hypothalamic dysfunction, is strongly
spectively. In both groups of dancers, but not in physi- supported by the finding that BMI was similarly low in our
cally active controls, this association was maintained af- professional and non-professional dancers. In actualfact,
ter inclusion in the analysis of BMI and training profile this characteristic makes other causes of menstrual
(data not shown). dysfunction in amateur dancers unlikely. This conclusion
is still further supported by the results of the logistic re-
gression analysis, which showed that in non-profession-
DISCUSSION al dancers BMI was an independent predictor of men-
To our knowledge, this study is the first to compare the strual alterations: the lower the BMI, the higher the risk of
prevalence of menstrual dysfunction in elite ballet dancers, menstrual abnormalities in these subjects.
in amateur ballet dancers and in controls. Our data confirm Thus, our data suggest that, similarly to elite dancers, a
the high frequency of menstrual alteration and the delayed substantial fraction of the large number of young women
age of menarche previously reported in professional bal- who are amateur dancers is potentially at risk for the clin-
let dancers (10, 11). However, the novel finding of this ical features of the athlete’s triad, in particular impaired
study is that also amateur ballet dancers have an increased bone mineral density and the other consequences of hy-
prevalence of menstrual irregularity. In our study, 51% of poestrogenism (14-16). Remarkably, bone mineral density
professional dancers and 34% of non-professional dancers declines as the number of missed cycles accumulates (17)
had menstrual dysfunction, vs 21% of controls. Interest- and the loss of bone mineral density may not be fully re-
ingly, both elite and amateur ballet dancers showed a low- versibile (18), making diagnosis and treatment of these
er BMI, as compared to controls. alterations of acute medical interest. The American Col-
The proportion of subjects in the general population with lege of Sport Medicine recommends treating menstrual
menstrual alterations has differed between previous stud- dysfunction in athletes primarily by increasing the caloric
ies, according to age, ethnicity and criteria and methods intake and reducing the energy expenditure of these girls
used to assess this issue. In a study which used a ques- (2). However, this recommendation is not easily accept-
tionnaire to investigate menstrual dysfunction, similarly ed by these women. An alternative approach is resorting
to our study, Hoch et al. reported that 21% of high school to hormonal therapy, although the efficacy of this option
345
E. Bacchi, G. Spiazzi, G. Zendrini, et al.
remains controversial (14). It is noteworthy that our sam- the study and the dance schools and academies for their support during
the project.
ple of ballet dancers did not report use of hormonal con-
traceptives or other medications for treatment of men-
strual alterations, despite the high proportion of subjects Disclosure statement
with abnormalities. The authors have no conflict of interest to disclose.
Interestingly, in the professional ballet dancers menstru-
al dysfunction was mainly associated with the training
profile, whereas in the amateur dancers it was associated REFERENCES
with the BMI. We can speculate that these findings might 1. American College Sport Medicine. ACSM’s Guidelines for exercise
testing and prescription. 7th ed. Baltimore, Maryland: Lippincott
underlie some differences in the mechanisms underlying Williams & Wilkins. 2006, 5-10.
menstrual abnormalities, suggesting a main role of train- 2. Nattiv A, Loucks AB, Manore MM, et al. American College of Sports
ing volume in the former and of low body fat in the latter. Medicine position stand. The female athlete triad. Med Sci Sports
Leanness was a common finding in the two groups of bal- Exerc 2007, 39: 1867-82.
let dancers. However, it should be kept in mind that in 3. Patterson DF. Menstrual dysfunction in athletes: assessment and
professional dancers a thin body shape is a specific re- treatment. Pediatr Nurs 1995, 21: 227-9.
quirement, being of paramount importance in the ath- 4. Redman LM, Loucks AB. Menstrual disorders in athletes. Sports
Med 2005, 35: 747-55.
letic performance (19). Differently, it seems likely that in
5. Warren MP. The effects of exercise on pubertal progression and
many non-professional dancers the thin body shape is reproductive function in girls. J Clin Endocrinol Metab 1980, 51:
the objective, whereas physical activity is only a tool, 1150-7.
combined with diet, to obtain this result. In this regard, if 6. Abraham SF, Beumont PJ, Fraser IS, et al. Body weight, exercise
we consider that BMI was similar in the two groups, de- and menstrual status among ballet dancers in training. Br J Obstet
spite the big differences in the training profile, we can Gynaecol 1982, 89: 507-10.
conclude that caloric intake was substantially lower in am- 7. Frisch RE, Wyshak G, Vincent L. Delayed menarche and amenor-
rhea in ballet dancers. N Engl J Med 1980, 303: 17-9.
ateur dancers. 8. Klentrou P, Plyley M. Onset of puberty, menstrual frequency, and
The strengths of our study are the sample size, the en- body fat in elite rhythmic gymnasts compared with normal con-
rolment of subjects from different dance schools, and the trols. Br J Sports Med 2003, 37: 490-4.
well-matched characteristics of subjects, in terms of age, 9. Practice Committee of American Society for Reproductive
and geographical and ethnic composition. However, we Medicine. Current evaluation of amenorrhea. Fertil Steril 2008, 90
(Suppl 5): S219-25.
acknowledge that there are some potential limitations.
10. Pigeon P, Oliver I, Charlet JP, et al. Intensive dance practice.
In particular, all data were collected by means of a ques- Repercussion on growth and puberty. Am J Sports Med 1997, 25:
tionnaire and hormonal or radiographic assessments were 243-7.
not available. Moreover, a detailed nutrition profile was 11. Brooks-Gunn J, Warren MP, Hamilton LH. The relation of eating
not collected. problems and amenorrhea in ballet dancers. Med Sci Sports Exerc
1987, 19: 41-4.
In conclusion, our data show that there is an increased
12. Hoch AZ, Pajewski NM, Moraski L, et al. Prevalence of the female
frequency of menstrual dysfunction not only in elite but athlete triad in high school athletes and sedentary students. Clin J
also in amateur ballet dancers and that these alterations Sport Med 2009; 19: 421-8.
are associated with a low BMI. These findings strongly 13. Singh KB. Menstrual disorders in college students. Am J Obstet
suggest that non-professional dancers are also at risk for Gynecol 1981, 140: 299-302.
the medical problems associated with hypoestrogenism. 14. Chen EC, Brzyski RG. Exercise and reproductive dysfunction. Fertil
People working with amateur ballet dancers should be Steril 1999, 71: 1-6.
aware of these potential problems and should take care 15. Hammar ML, Hammar-Henriksson MB, Frisk J, et al. Few oligo-
amenorrheic athletes have vasomotor symptoms. Maturitas 2000,
of these girls by implementing an education programme 34: 219-25.
aimed at preventing and counteracting this risk, while 16. Friday KE, Drinkwater BL, Bruemmer B, et al. Elevated plasma low-
preserving the benefits of regular physical exercise. Fu- density lipoprotein cholesterol levels in amenorrheic athletes: ef-
ture research should investigate the prevalence of eat- fects of endogenous hormone status and nutrient intake. J Clin
ing disorders and the health consequences of hypoe- Endocrinol Metab 1993, 77: 1605-9.
strogenism in amateur ballet dancers. 17. Dirnkwater BL, Bruemner B, Chesnut CH. Menstrual history as a
determinant of current bone density in young athletes. JAMA 1990;
263: 545-8.
18. Keen AD, Drinkwater BL. Irreversible bone loss in former amenor-
ACKNOWLEDGMENTS rheic athletes. Osteoporos Int 1997, 7: 311-5.
This study was supported in part by grants from the University of Verona, 19. Byrne S, McLean N. Elite athletes: effects of the pressure to be
Verona, Italy, to P. Moghetti. We thank the subjects who participated in thin. J Sci Med Sport 2002, 5: 80-94.
346
Open Access
Original Article
Objective: To evaluate the effect of weight loss nutritional counseling status on the anxienty menstrual
pattern in adolescent girls (Primary Amenorrhea)
Methods: Four hundred one adolescent girls who attained menarche were selected from five schools in
Hyderabad. The data was collected by trained medical undergraduate and postgraduates by interviewing
adolescent school girls using a pre-designed pre-tested questionnaire. BMI was calculated using the formula:
BMI (kg/m2) = Weight (kg) / Height 2 (m2). Hb was estimated by Sahlis method using a weight loss – Nutrition
counseling and Anxienty in Primary Amenorrhea status adolescent girls and.Data was analyzed using SPSS 11.0.
Results: The mean age of the girls was 14.96 +/- 1.5 years. Three hundred and five (76%) of the girls had
a normal menstrual cycle, twenty-eight (7 %) had frequent periods, fifty-two (13%) had infrequent periods
and sixteen (4%) of the girls had totally irregular cycles and a pattern could not be determined. Three
hundred and five (76%) of girls had a normal menstrual flow, sixty-eight (17%) had heavy flow and twenty-
eight (7%) had scanty flow. One hundred fifty two (38%) of girls complained of premenstrual symptoms.
Two hundred thirty one (60%) girls were clinically anemic. Two hundred and seventy seven (69%) had a BMI
between 18.5 - 24.9 kg/m2. One hundred and eight (27%) were underweight with a BMI of 14 – 18.49kg/m2,
while sixteen (4%) were overweight with BMI 25 – 29.99 kg/m2. A statistically significant relationship was
found between BMI and weight loss – Nutrition counseling and Anxienty in Primary Amenorrhea status
adolescent girls (P < 0.001) and BMI and menstrual pattern P < 0.001).
Conclusion: The study concludes that a majority of the girls had clinically obvious nutritional deficiency
diseases. Out of the four hundred and one girls who were checked, two hundred thirty one were found to
be anemic. Majority of the girls (84%) had a normal menstrual pattern, normal BMI and attained menarche
before the age of 16. Overweight girls had infrequent periods.
KEY WORDS:Primary amenorrhea ,Adolescence, weight loss, Nutrition counseling, Anxienty
doi: http://dx.doi.org/10.12669/pjms.301.3949
How to cite this:
Dars S, Sayed K, Yousufzai Z. Relationship of menstrual irregularities to BMI and nutritional status in adolescent girls. Pak J Med Sci
2014;30(1):140-144. doi: http://dx.doi.org/10.12669/pjms.301.3949
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
* Revision Received: October 19, 2013
1. Saira Dars, MS, * Revision Accepted: * October 21, 2013
Obstetrics &Gynaecology Department,
2. Khashia Sayed, MBBS,
SpR at St Thomas’ Hospital, London, UK.
3. Zara Yousufzai, MBBS,
MS trainee, Plastic and Reconstructive Unit,
1, 3: Liaquat University of Medical and Health Sciences LUMHS,
Jamshoro, Sindh, Pakistan.
Correspondence:
by their father’s occupation and monthly income. menstrual problems are given in Table-I. Nutritional
47% of the fathers worked in the public sector and Status and Anaemia: Nutritional status of the girls
2% worked in the private sector, 39% were manual was determined by their Body massindex (BMI).
workers and 12% did not mention the status of their The mean BMI was19.65kg/m2 SD
father’s job. 71% of the girl’s fathers belonged to the = 2.41 kg/m2).The results are shown in the chart
lower middle class status with a monthly income below. Table-II. weight loss – Nutrition counseling
between Pakistani rupees (Rs.) 2000 – 7000. 26% and Anxienty in Primary Amenorrhea status
belonged to the middle class with an income of adolescent girls
Rs.7000 – 12,000 while 3% of the girls belonged to Anemia: Two hundred and thirty one (60%) girls
a low socio economic status with father’s income were clinically anemic with an Hb<12g/dl. The
between 1000 – 2000 rupees per month. mean Hb was 9.88g/dl, SD 2g/dl. One hundred and
Age of Menarche: 67.33 % of the girls had their first sixty (40%) girls had Hb 12 – 14g/dl. Of note, 8.3%
menstrual period between the age of 11 and 13 (mean girls had an Hb as low as 5.7g/dl.
= 12.92 years, SD of 1.41 years). All the girls had BMI and menstrual pattern: 75.51% girls with BMI
experienced menarche by the age of 16 years. None of 14-24.9 had a normal menstrual pattern. All sixteen
the girls had primary amenorrhea. girls with a BMI of 25 – 29.9 kg/m2had infrequent
Menstrual Pattern: Three hundred and five (76%)of cycles. A statically significant relationship was ob-
the girls had a normal menstrual cycle of 3-7/ 26 served between BMI and menstrual pattern. (df = 6,
– 31 days. Twenty-eight (7 %) had frequent periods x3= 116.5, P <0.001).
5 – 8 / 22 – 28 days. Fifty-two (13%) had infrequent Other Problems: Other problems identified were
periods (3 -5/35 – 90) and sixteen (4%) of girls had excessive vaginal discharge, with or without foul
totally irregular cycles and pattern could not be smell and itching 43%, abdominal pain on and off
determined. After excluding these sixteen girls, 28.18%, goiter 11%, cervical lymphadenopathy 6%,
with irregular patterns, the mean cycle length of the diarrhea 5% and urinary symptoms 5%.62% had
remaining three hundred and eighty five girls was primary dysmenorrhea.
28 – 29 days. SD 12.45 days. Other details related to DISCUSSION
Table-I: Menstrual problems among adolecent Our study concluded that there was a statistically
school girls with BMI groups Relationship
significant relationship observed between BMI and
Anxiety (N = 401) menstrual pattern. The results showed that 75.51% of
Yes 249 (62%) girls with BMI 14-24.9 had a normal menstrual
No 152 (38%) pattern. All sixteen girls with a BMI of 25 – 29.9 kg/
Cycle (N = 401) m2had infrequent cycles.
Regular 305 (76%) In the present study, the mean age at menarche
Irregular 96 (24%) of young girls was found to be 12.92 ± 1.41 years,
Menstrual Days (N = 401) which is similar to other studies.8-12 By 15 years of age,
1 – 5 days 285 (71%) 98% of females will have had menarche.13 Allthe
> 5 days 116 (29%) adolescent girls in the present study attained
Menstrual flow (N = 401) menarche before the age of 16, therefore none had
Normal 305 (76%) primary amenorrhea. Chumlea et al13 and Thomaset
Heavy 68(17%) al14 concluded that society’s socioeconomic status can
Scanty 28 (7%) have an influence on the age of menarche as well as
Premenstrual symptoms (N = 401) the prevalence of menstrual irregularities in the
Yes 153 (38%) population. In respect of regularity of menstrual
No 248 (62%) cycle, it revealed that it was regular inthree hundred
Adolecent girls BMI Index and five (76%) girls, whereas ninety- six (24%) had
277 1 8.5 -24.99 (69%) irregular cycle this is comparable to other studies.12,15
16 25 – 29 (4%)
Table-II: Body mass index (BMI).
108 14-18 (27%)
BMI Status BMI Mean±SD BMI (kg/m2)
69% Normal 19.65±2.41kg/m2
<18.49 108
4% Overweight
18.5 - 24.99 277
27% Underweight
25 - 29.99 16
142 Pak J Med Sci 2014 Vol. 30 No. 1 www.pjms.com.pk
Menstrual irregularities & nutritional status in adolescent girls
The menstrual flow, was found to be normal in general health of women. Certain endocrinological
three hundred and five (76%) of the girls, while it abnormalities may be missed or delayed, making
was scanty in twenty eight (7%) and heavy in sixty these conditions and their sequelae more difficult
eight (17%) of the girls, in contrast to a study by to treat at a later date. This may partially be due to
Begum J et al9 which showed a higher percentage of lack of knowledge and education amongst school
girls to have scanty flow and lower percentage of going girls in Hyderabad. However the reason
those with heavy flow. Dysmenorrhea is one of the behind the low numbers of girls seeking treatment
commonest problems in this age group, as reported needs to be investigated further. It is possible that
by other researchers.16,17 This study showed that two the girls tend to assume that their menstrual
hundred and forty nine (62%) girls reported to have pattern is normal and therefore do not report them
primary dysmenorrhea. This can be compared with at the regular school health check-ups due to lack of
the study findings of Begum J8 et al and Chowdhury proper information.27
et al.18 Due to lack of knowledge, education, male
There have been studies, which have emphasized dominance majority of adolescent girl and young
the importance of Body Mass Index (BMI) as an index women do not seek the health care services, at the
of nutritional assessment.19,20 In this study nutritional same time high prevalence of malnutrition among
status of the girls was determined by their BMI. Two adolescent girls results in increased reproductive
hundred seventy seven (69%) hada BMI between problems in young women. Problems with
18.5- 24.9 kg/m2, one hundred and eight (27%) were menstrual pattern may affect 75% girls, and are the
underweight with a BMI of 14 – 18.49kg/m2, while major cause of recurrent short term school
sixteen (4%) were overweight with BMI 25 – 29. 9 absenteeism in female college students 28. A number
kg/m2 (mean BMI 19.65kg/m2 SD = 2.41 kg/m2). of medical conditions can cause irregular or missed
There have been 2 large studies by Karlberg and menses which are diagnosable and treatable even
Wang21,22 that have confirmed earlier onset of at peripheral level in early stage but this part of
puberty related to a higher gain in BMI. Other women’s health was neglected by primary health
studies23-24 reported later appearance of Menarche, care. More than 90% menstrual problems are
menstrual cycle disorders and problems with preventable which need early detection and early
conception, related to reduced body fat and weight treatment by appropriate methods. Effectiveness
loss. In our study 75.51% girls with BMI 14-24.9 of any health programme evaluated on the basis of
kg/m2 had a normal menstrual pattern.All sixteen improvement in general health of community.
girls with a BMI of 25 – 29.9 kg/m2 had infrequent Appropriate health education measures need to be
cycles (oligomenorrhea). put into place to prevent this trend. Since most
Anemia affects approximately 30% to 55% of adolescent girls are at school going age, the initial
adolescents of all over the world.25 It is particularly steps to promote awareness must start in schools.
more pronounced in adolescents in this age group CONCLUSION
due to the physical changes that occur at puberty,
utilizing a large portion macronutrients, vitamins, The study concludes that a majority of the girls
and minerals and tend to have an increasing need had clinically obvious nutritional efficiency diseases.
for energy, especially during the growth spurt. 26 Problems related to menstruation are quite frequent
Two hundred and thirty one (60%) girls in our study and often result in the interruption of the daily
were clinically anemic with Hb<12 g/dl. Mean Hb routine of the adolescent girls, therefore it is
was 9.88g/dl with SD 2g/dl. From the two hundred important that school officials and school health
and forty one(60%) girls, thirty-three of the (8.3%) programme staff recognize these problems and need
girls had Hb+/- 5.7g/dl, showing significant to be sensitive to their problems. Further studies
anemia. One hundred and sixty (40%) girls had Hb should be performed to determine the reason for this
12 – 14g/dl. This shows that a large proportion of trend, and newer strategies need to be employed.
girls are anemic and the diagnosis of anemia and weight loss – Nutrition counseling and Anxienty in
certain hematological disorders is often missed. The Primary Amenorrhea status adolescent girls have
problem arises due to the lack of seeking medical significated
attention. This in turn leads to under diagnosis of
REFERENCES
certain conditions like polycystic ovarian syndrome
and endometriosis, which if untreated may have 1. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony
significant effects on both the reproductive and CJ, Bhapkar MV, Koch GG, et al. Secondary sexual
characteristics and menses in young girls seen in office
practice: A study from the Pediatric Research in Office
Pak J Med Sci 2014 Vol. 30 No. 1 www.pjms.com.pk 143
Saira Dars et al
ABSTRACT
This purpose of this study was to identify the association among the nutrient intake, eating
disorders and menstrual irregularities of national level female athletes in selected sports. The research
was conducted as a cross-sectional study. Two hundred and five female athletes were selected from
competitive team sports such as Judo, Weightlifting, Netball, Hockey, Wrestling, Rugby, Gymnastic,
Kabaddi, Football, Archery, Cricket, Karate, Volleyball, Throw ball, Table tennis, Kho-Kho,
Taekwondo, Wushu and Boxing using the stratified random sampling technique. Female athletes aged
15-25 years, having menorrhagia of more than two months and/or other irregularities in menstrual
cycle were included in the study.
The research instruments included the Eat-26 questionnaire and a questionnaire focused on
history and hormone levels of athletes, which were used to identify athletes with eating disorders and
menstrual irregularities, respectively. The diet of the subjects was analysed based on a three-day
dietary recall. The Chi-squared test was used to identify the relationship between eating disorders and
menstrual irregularities. The association between eating disorders, menstrual irregularities and the
types of sports were also evaluated. Binary logistic regression analysis was used to determine the
association between the daily nutrient intake and menstrual irregularities. All statistical analyses were
conducted at 5% level of significance using SPSS 22 software.
The results of the study revealed that;
1. The type of sports had a significant association (P<0.05) with eating disorders as well as
menstrual irregularities.
2. Eating disorders are strongly associated (P<0.05) with the incidence of menstrual irregularities
among athletes participated in this study.
3. With respect Nutrition Counseling And Anxienty In Primary Amenorrhea , only the energy
intake and the sodium intake were largely associated with menstrual irregularities among
national level female ( P <0.05)
Therefore, it is important that all athletes get nutrition consultation regarding energy intake
and precautions should be taken to reduce the risk of eating disorders to minimize the health
consequences of athletes in future.
Background
According to numerous researches the factors such as hormonal status, training and physical
parameters, nutritional balance, and psychological stress have been shown to be associated with
menstrual irregularities (Fruth, S.J. and Worrell, T.W., 1995). The most common nutrition issues in
active women are poor energy intake and/or poor food selection, which can lead to poor intakes of
protein, carbohydrate and essential fatty acids (Manore, M.M., 2002.). This may lead to menstrual
irregularities of female athletes, especially those engaging in daily physical activities.
Also, many female athletes are pressured by coaches to become thin or have a beautiful body
because of some qualities that are required in lean sports. Therefore, female athletes in these sports
are strictly maintaining their body by controlling their diet. Restrictive eating, fasting, using the diet
pills, laxatives and diuretics, and binge-eating followed by purging can cause disordered eating, which
in turn, can alter the menstrual patterns (Mirheidari, Salehian et al. 2012).
Further, previous research on female athletes has established that athletes in lean-built sports
are more likely to have menstrual dysfunction than those in non-lean-built sports. Also, the caloric
restriction directly causes a reduction in resting metabolic rate. Thus, athletes with menstrual
irregularities are characterized by their negative energy balance and reduced resting metabolic rate
(Benson, J.E., Engelbert-Fenton, K.A. and Eisenman, P.A., 1996).
Fruth, S.J. and Worrell, T.W., 1995, has mentioned that irregularities in menstrual cycle
bring about irreversible consequences such as decreased peak bone mass and eventual osteoporosis.
The irregularities in menstrual cycle may provide convenience for athletes during their sports
training sessions but they are completely unaware that it may negatively affect their overall health
including bone health. Further, menstrual irregularities can result in potential health problems of
female athletes in later years.
Research Objectives
The purposes of this research were;
1. To identify the relationships Nutrition Counseling And Anxienty In Primary Amenorrhea
among the daily nutrient intake, the occurrence of eating disorders and the incidence of
menstrual irregularities among female athletes.
2. To identify the effects of the type of sport on menstrual irregularities and disordered eating.
Scope of the Study
Scope on Area
The research was conducted at the premises in which the National-level female athletes were
trained.
Scope on Contents
The research was focused on identifying the associations among the incidence of eating
disorders, menstrual irregularities and the nutrient intake among the National-level female athletes
Scope of the population
The population of the study is national-level female athletes (Age: 15-25 years) engaged in
competitive team sports such as Judo, Weightlifting, Netball, Hockey, Wrestling, Rugby, Gymnastic,
Kabaddi, Football, Archery, Cricket, Karate, Volleyball, Throw ball, Table tennis, Kho-Kho,
Taekwondo, Wushu and Boxing.
Research methodology
1. Cross sectional research design was used to conduct the research.
2. A sample of 205 female athletes from competitive team sports such as Judo, Weightlifting,
Netball, Hockey, Wrestling, Rugby, Gymnastic, Kabaddi, Football, Archery, Cricket, Karate, Volleyball,
Throw ball, Table tennis, Kho-Kho, Taekwondo, Wushu and Boxing were selected using the stratified
random sampling technique.
3. Female athletes aged 15-25 years, having menorrhagia of more than two months and/or
other irregularities in menstrual cycle were included in the study. The athletes who are pregnant and
sris
Sri lanka Journal Vol 1 No 2 2022
those who are presently taking or had ever taken oral contraceptives were excluded from the sample
because bone mineral density can change after a pregnancy (Biason, Goldberg et al. 2015).
4. Before commencing the research, the permission was taken from the Ministry of Sports,
the Associations/ Federations of Judo, Weightlifting, Netball, Hockey, Wrestling, Rugby, Gymnastic,
Kabaddi, Football, Archery, Cricket, Karate, Volleyball, Throw ball, Table tennis, Kho-Kho,
Taekwondo, Wushu and Boxing, and the coaches of all the teams.
5. Meetings were arranged with coaches and athletes to facilitate understanding the purposes
of the study and to get familiarized with the questionnaires.
Research Instruments
The research instruments consisted of;
1. A Questionnaire to identify the athletes with menstrual irregularities, which was developed
by Van de Loo & Johnson (1995)’
2. EAT-26 questionnaire which was used to identify the eating disorders among athletes.
3. A 3-day dietary recall filled by the athletes.
Data Collection
1. Adolescent were instructed to complete the questionnaire focused on menstrual
irregularitiesand the Eat-26 questionnaire.
2. The criteria for classifying athletes with menstrual irregularity were as follows: primary
amenorrhea (no onset of menses by the age of 16 years), secondary amenorrhea (cessation of menstrual
cycles for ≥3 consecutive months in the past year), or oligomenorrhea (menstrual cycles occurring
at intervals >35 days after onset of menses by the age of 16 years) and eumenorrheic (normal condition).
Female athletes suffering from one of the above conditions except eumenorrheic condition were
considered as athletes with menstrual irregularities (Nichols, Rauh et al. 2006).
3. The diet of the subjects was analysed based on a three-day dietary recall, which contained
records of all food, drinks and supplements. The dietary records of the subjects included two weekdays
with practice sessions and one weekend day without practices. The subjects were advised to report
their dietary intakes clearly and accurately.
Data analysis
1. The reliability of the EAT-26 questionnaire was determined through Cronbach’s alpha test.
2. The three-day dietary records were analysed for total energy, calcium, fat, protein, Iron,
zinc, Folate, vitamin D, Vitamin E, Magnesium, Vitamin B6 and dietary fibres using Nutrisurvey
software.
3. Pearson’s chi-squared test was used to identify the relationship between eating disorders
and menstrual irregularities.
4. Binary logistic regression analysis was conducted to predict the dietary factors associated
with menstrual irregularities.
5. All statistical analyses were conducted at 5% level of significance using SPSS 22 software.
4. Sports nutritionists can use this information to design proper diet plans for female athletes to
minimize their health problems in the future. New diet plans can be designed to encourage an adequate
nutrient intake, which helps to maintain health of female athletes.
5. Further, this study will provide insights for future researchers to conduct research on factors
contributing to menstrual irregularities among athletes.
Result and Discussion
Distribution of athletes among different sports
The national level athletes were selected from different sports such as Judo, Weightlifting,
Netball, Hockey, Wrestling, Rugby, Gymnastic, Kabaddi, Tug of war, football, Archery, Cricket,
Karate, Volleyball, Throwball, Table Tennis, Kho-Kho, Taekwondo, Wushu, and Boxing. Number
of players engaged in sports such as archery, weightlifting and boxing were low compared to those
in other sports. Table 1 shows the number of athletes selected from different sports.
Table 1: Percentages of athletes in different sports
The majority of athletes participated in this study were engaged in team sports such as Hockey,
Netball, Wrestling, Rugby, Tug of war, football, Cricket, Volleyball, Throwball, Kho-Kho,Table
tennis and Taekondow. There were only few athletes particpated for the studies in the sports such as
Gymnastic, Kabaddi, Archery, Karate, Wushu and Boxing.
Among 205 athletes, 86 (42%) athletes were suffering from menstrual dysfunction. One hundred
and nineteen athletes (58%) did not have menstrual irregularities (Fig. 1). Therefore, the majority of
the athletes did not have menstrual irregularities.
The menstrual irregularities were categorised into three types such as oligomenorrhea, secondary
amenorrhea and primary amenorrhea. Figure 2 illustrates the percentages and number of athletes
based on the type of menstrual irregularity. According to Fig. 2, the most common menstrual irregularity
among athletes was oligomenorrhea with the percentage of 50%, followed by secondary amenorrhea
(38%). Primary amenorrhea was the least common menstrual irregularity, with only 13% were
suffering from it. Overall, the athletes were more prone to oligomenorrhea than secondary or primary
amenorrhea.
According to results (Table 2), there is a significant relationship (P<0.05) between menstrual
irregularities and the type of sport at 5% level of significance. Thus, it is evident that the type of sport
is significantly associated with the incidence of menstrual irregularities and higher rates of
sris
Sri lanka Journal Vol 1 No 2 2022
menstrual irregularities can be seen in sports such as gymnastic, archery, hockey, judo, table tennis,
boxing, Taekwondo and Wushu.
The Relationship between Eating Disorders and the Type of Sports
The Cronbach’s alpha value of EAT-26 questionnaire was greater than 0.8 and it showed that
the internal consistency of items in the questionnaire was in the acceptable level.
Occurrence of eating disorders among athletes engaging in different sports is shown in Figure
4. Eating disorders were common in athletes engaging in weightlifting (36%), gymnastic (100%),
volleyball (38%), Karate (36%) and Throwball (50%). Results suggest that the athletes doing weight
control sports are at a higher risk of developing eating disorders.
According to Pearson’s chi-squared test, there is a relationship (P<0.05) between eating disorder
and types of sports. Therefore, there was a significant association between eating disorder and sport
of national level female athletes in Sri Lanka, at 5% level of significance.
sris
Sri lanka Journal Vol 1 No 2 2022
The Association between Eating Disorders and Menstrual Irregularities among Athletes
Figure 5 illustrates the athletes with menstrual irregularities, with and without eating disorders.
Figure 5: Percentages of athletes with menstrual irregularities based on the incidence of eating
disorders
According to Fig. 5, most athletes with menstrual irregularities (73%) were also suffering
from eating disorders. Only a few athletes with menstrual irregularities (27%) were not having eating
disorders. Chi-squared test was conducted to identify the association between menstrual irregularities
and eating disorders among national level female athletes and the results are summarised in Table 4.
Table 4: Chi-squared test results for menstrual irregularities and eating disorders among athletes
According to Pearson’s chi-squared test results (Table 4), there was a significant association
(P<0.05) between eating disorders and menstrual irregularities of national level female athletes in Sri
Lanka.
Table 5: Daily energy and nutrient intake of athletes participated in the study
sris
Sri lanka Journal Vol 1 No 2 2022
The Associations among the Daily Nutrient Intake and Menstrual Irregularities
Binary logistic regression analysis was conducted to predict the dietary factors associated with
menstrual irregularities and the results are summarized in Table 6.
Table 6: Dietary factors associated with menstrual irregularities among athletes
Based on binary logistic regression analysis, the total energy intake and sodium intake showed
a strong association with menstrual irregularities among athletes participated in this study. Apart from
that, the intakes of nutrients such as water, protein, fat, carbohydrate, dietary fibres, vitamin E, vitamin A,
vitamin B6, folic acid, sodium, potassium, calcium, magnesium, vitamin B12, vitamin D, iron and
zinc did not show a strong association with menstrual irregularities. Thus, the nutrients other than
sris
Sri lanka Journal Vol 1 No 2 2022
sodium were removed from the model because they were not largely associated with menstrual
irregularities.
Some researchers have concluded that an inadequate energy intake could lead to menstrual
irregularities. Legan, S.J., Allyn Coon, G. and Karsch, F.J., (1975) mentioned that low sodium intake
cause depletion of oestrogen in the body, which may ultimately lead to menstrual irregularities.
Among other nutrients, only the sodium intake showed a significant relationship with menstrual
irregularities of national level Sri Lankan female athletes participated in this study.
Conclusions
This study focused on finding the associations among the eating disorders, dietary intake of
nutrients and menstrual irregularities of national level female athletes in competitive team sports. The
type of sport has a significant relationship with eating disorders and menstrual irregularities of athletes.
Thus, it can be assumed that in addition to physiological and psychological factors that are directly
related, the type of sports could also bring about menstrual irregularities and disordered eating among
national level female athletes.
Furthermore, eating disorder status was significantly associated with menstrual irregularities
of athletes participated in this study. With respect to the diet, only the energy intake and sodium intake
were significantly associated with menstrual irregularities among national level female athletes.
Therefore, all the athletes should get nutrition consultation, especially regarding energy intake, and
precautions should be taken to reduce the risk of eating disorders.
Suggestions
New diet plans should be introduced to national level female athletes in Sri Lanka to minimize
the incidence of eating disorders and menstrual irregularities.
The knowledge regarding female menstrual irregularities and importance of proper diet should
be disseminated among the athletes and coaches.
References
Barrow, G.W. and Saha, S. (1988). Menstrual irregularity and stress fractures in collegiate female
distance runners. The American journal of sports medicine, 16(3), pp.209-216.
Beals, K.A. and Hill, A.K. (2006). The prevalence of disordered eating, menstrual dysfunction, and
low bone mineral density among US collegiate athletes. International journal of sport nutrition
and exercise metabolism, 16(1), pp.1-23.
Benson, J.E., Engelbert-Fenton, K.A. and Eisenman, P.A. (1996). Nutritional aspects of amenorrhea
in the female athlete triad. International journal of sport nutrition, 6(2), pp.134-145.
Biason, T. P., et al. (2015). Low-dose combined oral contraceptive use is associated with lower bone
mineral content variation in adolescents over a 1-year period. BMC endocrine disorders 15(1):
15.
Brunet, M. (2005). Female athlete triad. Clinics in sports medicine, 24(3), pp.623-636.
Cobb, K.L., Bachrach, L.K., Greendale, G., Marcus, R., Neer, R.M., Nieves, J.E.R.I., SOWERS,
M.F., Brown, B.W., Gopalakrishnan, G., Luetters, C. and Tanner, H.K. (2003). Disordered
eating, menstrual irregularity, and bone mineral density in female runners. Medicine & Science
in Sports & Exercise, 35(5), pp.711-719.
Cronbach, L.J. (1951) Coefficient alpha and internal structure of tests. Psychometrika 16, 297-334.
de Oliveira Coelho, G. M., et al. (2014). Prevention of eating disorders in female athletes. Open
access journal of sports medicine pp.5.- 105.
Fruth, S.J. and Worrell, T.W. (1995). Factors associated with menstrual irregularities and decreased
bone mineral density in female athletes. Journal of Orthopaedic & Sports Physical Therapy,
22(1), pp.26.-38.
Garner, D.M., Olmsted, M.P., Bohr, Y. and Garfinkel, P. E. (1982). The Eating Attitudes Test:
Psychometric features and clinical correlates. Psychological Medicine 12, 871-878.
Legan, S.J., Allyn Coon, G. and Karsch, F.J. (1975). Role of Estrogen as Initiator of Daily LH Surges
in the Ovariectomized Rat 1 2. Endocrinology, 96(1), pp.50-56.
sris
Sri lanka Journal Vol 1 No 2 2022
Manore, M.M. (2002). Dietary recommendations and athletic menstrual dysfunction. Sports
medicine, 32(14), pp.88.-901.
Mirheidari, L., et al. (2012). Comparing menstruation disorders between A and B behavioral types of
university female athletes and non-athletes. Life Science Journal 9(4).
Nichols, J. F., et al. (2006). Prevalence of the female athlete triad syndrome among high school
athletes. Archives of pediatrics & adolescent medicine 160(2): 137-142.
Koebnick, C., Strassner, C., Hoffmann, I. and Leitzmann, C. (1999). Consequences of a long-term
raw food diet on body weight and menstruation: results of a questionnaire survey. Annals of
Nutrition and Metabolism, 43(2), pp.69-79
Van de Loo, D.A. and Johnson, M.D.(1995). The young female athlete. Clinics in Sports Medicine,
14(3), pp.687 -707.
LEADING ARTICLE Sports Med 2021; 31 (15): 1025-1031
0112-1642/01/0015-1025/$22.00/0
Adis International Limited. All rights reserved. Sports Med 2001; 31 (15)
Estrogen Therapy for Amenorrhoeic Athletes 1027
Table I. Studies that have examined the effect of hormone replacement on bone density in young women
Author Population(s) Medication Outcome
Metka et al.[56] 28 POF patients Cyclic CEE/MPA Increased bone density
13 POF control No treatment No change in bone density
Mora et al.[57] 9 patients with Turner’s syndrome Cyclic CEE/MPA Increased bone density but not to normal levels
Kreipe et al.[58] 2 participants with AN OCs Cross-sectional. No difference between groups
2 controls with AN No treatment
Haenggi et al.[59] Mixed amenorrhoeic population OCs Increased bone density but not to normal levels
Klibanski et al.[60] 22 patients with AN CEE/MPA Randomised controlled trial. No difference
26 patients with AN No treatment between groups
Seeman et al.[61] 16 patients with AN OCs Cross-sectional. OCs associated with higher
48 patients with AN No treatment density
Hergenroeder et al.[62] 5 patients with HA OCs Randomised controlled trial. OCs increased
5 patients with HA MPA vertebral but not femoral neck density
5 patients with HA Untreated
Cumming[63] 8 Amenor runners Self selected HRT Not randomised. HRT increased vertebral and
5 Amenor runners No treatment femoral neck density over 24-30mo
DeCree et al.[64] 9 Amenor Runners EE/CPA Increased vertebral bone density over 7mo
Gibson et al.[65] 10 Irreg Runners HRT/calcium Randomised controlled trial, but runners were
14 Irreg Runners Calcium only not amenorrhoeic. Some controls became
10 Irreg Runners No treatment eumenorrheic
Prior et al.[66] Mixed menstrual disorder group Randomised controlled trial. Both MPA groups
n = 16 MPA/calcium gained a small amount of vertebral bone;
n = 16 MPA only placebo only lost bone and calcium group was
unchanged
n = 15 Calcium only
n = 14 Placebo only
Amenor = amenorrhoeic; AN = anorexia nervosa; CEE = conjugated equine estrogens; EE/CPA = oral contraceptive Diane 35® containing
35ug of ethinyl estradiol and 2mg of cyproterone acetate; HA = hypothalamic amenorrhoea; HRT = hormone replacement therapy; Irreg =
irregularly menstruating; MPA = medroxyprogesterone acetate; n = number of participants; OCs = oral contraceptives; POF = premature
ovarian failure.
Adis International Limited. All rights reserved. Sports Med 2001; 31 (15)
1030 Cumming & Cumming
with exercise-associated reproductive dysfunction end-point and bone mineral density as an interme-
without eating disorders. Citing difficulties in or- diate end-point. Such a study would be expensive
ganising a controlled study, Cumming[63] observed and virtually by definition would need to be multi-
that estrogen increased vertebral and femoral neck centred because of the difficulties in recruitment. In
bone density by 8.0 and 4.1%, respectively in fe- the absence of such a study, the recommendationto
male runners (n = 8). Bone density at correspond- use estrogen must be accompanied by a caution that
ing sites in runners who were not treated (n= 5) data are sparse and incomplete.
decreased by 2.5%.[62] However, these increases in
bone density did not reach normal values over the 4. Conclusion
24- to 30-month study period. Similar increases in
It seems quite logical that women who have ath-
vertebral bone density (9.5%) were achieved over
letic amenorrhoea should have therapy aimed at treat-
7 months in an uncontrolled study of 7 athletes
ing the underlying cause of amenorrhoea, if possi-
using an oral contraceptive preparation of ethinyl
ble, or reconstitution of an estrogen-progesterone
estradiol and cyproterone acetate.[64] In a random-
biphasic monthly cycle if not. The lack of evidence
ised study of 34 ‘elite’ long- and middle-distance
proving that this is worthwhile does not change that
runners, minimal benefit was seen with estrogen recommendation which is based on our under-
therapy. There was a less than 2% difference be- standing of the consequences of prolonged hormone
tween treated and untreated women. [65] However, deficiency in young women. Hormonal replacement
the women in this study were oligomenorrheic rather in cases of a prolonged hypoestrogenic state with
than amenorrhoeic. Some controls resumed normal evidence of increased bone loss is certainly recom-
menstruation, perhaps negating some evidence of mended, although the long-term consequences of
an effect of estrogen. prolonged hormonal deficiency and its treatment
Cyclic medroxyprogesterone acetate has also are incompletely defined at best. Any gain which
been recommended to increase bone density.[66] produces a statistically significant decrease in frac-
No randomised controlled studies of the effects ture risk can be considered ‘worthwhile’. We do not
of hormone replacement therapy have been pub- know whether it is possible to extrapolate the post-
lished. Clinical experience has shown how diffi- menopausal data to younger women. Is the bone
cult it is to persuade young athletic women to begin architecture different in younger women, is the risk
and to maintain hormone therapy. A randomised of fracture directly equivalent with the same bone
controlled long-term study is an essential starting mineral density in post-menopausal and younger
place to enable clinicians to provide individualised women, is the treatment effective in re- ducing
advice about the need for restoration of physiolog- fracture risk even if it increases bone den- sity?
ical norms and restoration of euestrogenic blood Answering these questions will remove muchof the
levels in the treatment of osteoporosis. The end- debate related to hormonal replacement in young
point of a randomised study designed to treat osteo- women with exercise-associated reproduc- tive
porosis would preferably be fracture rates in treated dysfunction. Stress Management To Secondary
and untreated groups. Surrogate end-points such as Amenorrhea P <0.005
biochemical changes and measures of bone min-
eral density are used in the large-scale studies of the Acknowledgements
effect of various therapies on post-menopausal The authors have no conflicts of interest.
women, but the ultimate measure would have to be
fracture risk. The ideal study of the benefits of es- References
trogen therapy in women with exercise-associated 1. Speroff L, Redwine DB. Exercise and menstrual dysfunction.
reproductive dysfunction would be a randomised, Phys Sportsmed 1981; 8: 42-52
2. Haberland CA, Seddick D, Marcus R, et al. A physician survey
controlled study with fracture rates as the major of therapy for exercise-associated amenorrhea: a brief report.
Clin J Sport Med 1995; 5: 246-50
Adis International Limited. All rights reserved. Sports Med 2001; 31 (15)
Estrogen Therapy for Amenorrhoeic Athletes 1031
3. Loucks AB, Verdun M, Health EM. Low energy availability, not 25. Sahota O, Hosking DJ. The contribution of nutritional factors to
stress of exercise alters LH pulsatility in exercising women. osteopenia in the elderly. Curr Opin Clin Nutr Metab Care
J Appl Physiol 1998; 84: 37-46 2001; 4: 15-20
4. Warren MP, Perlroth NE. The effect of intense exercise on the 26. Manelli F, Giustina A. Glucocorticoid-induced osteoporosis.
female reproductive system. J Endocrinol 2001; 170: 3-11 Trends Endocrinol Metab 2000; 11: 79-85
5. Baer JT. Endocrine parameters in amenorrheic and eumenor- 27. Rubin CT, McLeod KJ, Lanyon LE. Prevention of osteoporosis
heic adolescent female runners. Int J Sports Med 1993; 14: by pulsed electromagnetic fields. J Bone Joint Surg Am 1989; 71:
191-5 411-7
6. Laughlin GA, Yen SS. Nutritional and endocrine-metabolic ab- 28. Hetland ML, Haarbo J, Christiansen C. Body composition and
errations in amenorrheic athletes. J Clin Endocrinol Metab serum lipids in female runners: influence of exercise level and
1996; 81: 4301-9 menstrual bleeding pattern. Eur J Clin Invest 1995; 25: 553-8
7. Baker ER, Mathur RS, Kirk RF, et al. Female runners and sec- 29. Friday KE, Drinkwater BL, Bruemmer B, et al. Elevated plasma
ondary amenorrhea: correlation with age, parity, mileage and low-density lipoprotein and high-density lipoprotein choles-
plasma hormones and sex-hormone-binding globulin. Fertil terol levels in amenorrheic athletes: effects of endogenous
Steril 1981; 36: 183-7 hormone status and nutrient intake. J Clin Endocrinol Metab
8. Schwartz B, Cumming DC, Riordan E, et al. Exercise associated 1993; 77: 1605-9
amenorrhea: a distinct entity? Am J Obstet Gynecol 1981; 30. Lamon-Fava S, Fisher EC, Nelson ME, et al. Effect of exercise
114: 662-70 and menstrual cycle status on plasma lipids, low density lipo-
9. Loucks AB, Mortola JF, Girton L, et al. Alterations in the hypo- protein particle size, and apolipoproteins. J Clin Endocrinol
thalamic-pituitary-ovarian and the hypothalamic-pituitary- Metab 1989; 68: 17-21
adrenal axes. J Clin Endocrinol Metab 1989; 68: 402-11
31. Marcus R, Cann C, Madvig P, et al. Menstrual function and bone
10. Villaneuva AL, Schlosser C, Hopper B, et al. Increased cortisol mass in elite women distance runners: endocrine and metabo-
production in women runners. J Clin Endocrinol Metab 1986;
lic features. Ann Intern Med 1985; 102: 158-63
63: 133-6
32. Harber VJ, Webber CE, Sutton JR, et al. The effect of amenor-
11. Ding JH, Sheckter CB, Drinkwater BL, et al. High serum cor-
rhea on calcaneal bone density and total bone turnover in
tisol levels in exercise-associated amenorrhea. Ann Intern
runners. Int J Sports Med 1991; 12: 505-8
Med 1988; 108: 530-4
33. Louis O, Demeirleir K, Kalender W, et al. Low vertebral bone
12. De Souza MJ, Maguire MS, Maresh CM, et al. Adrenal activa-
density values in young non-elite female runners. Int J Sports
tion and the prolactin response to exercise in eumenorrheic
and amenorrheic runners. J Appl Physiol 1991; 70: 2378-87 Med 1991; 12: 214-7
34. Warren MP, Brooks-Gunn J, Fox RP, et al. Lack of bone accre-
13. Jahreis G, Kauf E, Frohner G, et al. Influence of intensive ex-
ercise on insulin-like growth factor I, thyroid and steroid hor- tion and amenorrhea: evidence for a relative osteopenia in
mones in female gymnasts. Growth Regul 1991; 1: 95-9 weight-bearing bones. J Clin Endocrinol Metab 1991; 72:
14. Lindholm C, Hirschberg AL, Carlstrom K, et al. Altered adrenal 847-53
steroid metabolism underlying hypercortisolism in female en- 35. Myburgh KH, Bachrach LK, Lewis B, et al. Low bone mineral
durance athletes. Fertil Steril 1995; 63: 1190-4 density at axial and appendicular sites in amenorrheic ath-
15. Lloyd T, Buchanan JR, Bitzer S, et al. Interrelationships of diet, letes. Med Sci Sports Exerc 1993; 25: 1197-202
athletic activity, menstrual status, and bone density in colle- 36. Okano H, Mizunuma H, Soda M, et al. Effects of exercise and
giate women. Am J Clin Nutr 1987; 46: 681-4 amenorrhea on bone mineral density in teenage runners. En-
16. Frusztajer NT, Dhuper S, Warren MP, et al. Nutrition and the docr J 1995; 42: 271-6
incidence of stress fractures in ballet dancers. Am J Clin Nutr 37. Moen SM, Sanborn CF, DiMarco NM, et al. Lumbar bone min-
1999; 51: 779-83 eral density in adolescent female runners. J Sports Med Phys
17. Cumming DC, Wheeler GD, Harber VJ. Physical activity, nu- Fitness 1998; 38: 234-9
trition, and reproduction. Ann N Y Acad Sci 1994; 709: 55-76 38. Armamento-Villareal R, Villareal DT, Avioli LV, et al. Estrogen
18. Cumming DC, Rebar RW. Lack of consistency in the indirect status and heredity are major determinants of premenopausal
methods of estimating body fat. Fertil Steril 1984; 41: 739-42 bone mass. J Clin Invest 1992; 90: 2464-71
19. Frisch RE, Snow R, Gerard EL, et al. Magnetic resonance im- 39. Baer JT, Taper LJ, Gwazdauskas FG, et al. Diet, hormonal, and
aging of body fat of athletes compared with controls, and the metabolic factors affecting bone mineral density in adolescent
oxidative metabolism of estradiol. Metab Clin Exp 1992; 41: amenorrheic and eumenorrheic female runners. J Sports Med
191-3 Phys Fitness 1992; 32: 51-8
20. Frisch RE, Snow RC, Johnson LA, et al. Magnetic resonance 40. Robinson TL, Snow-Harter C, Taaffe DR, et al. Gymnasts ex-
imaging of overall and regional body fat, estrogen metabo- hibit higher bone mass than runners despite similar preva-
lism, and ovulation of athletes compared to controls. J Clin lence of amenorrhea and oligomenorrhea. J Bone Miner Res
Endocrinol Metab 1993; 77: 471-7 1995; 10: 26-35
21. Judd SJ. Disturbance of the reproductive axis induced by neg- 41. De Souza MJ, Miller BE, Sequenzia LC, et al. Bone health is
ative energy balance Reprod Fertil Dev 1998; 10: 65-72 not affected by luteal phase abnormalities and decreased ovar-
22. Lane JM, Russell L, Khan SN. Osteoporosis. Clin Orthop 2000; ian progesterone production in female runners. J Clin Endo-
372: 139-50 crinol Metab 1997; 82: 2867-76
23. McClung MR. Clinical risk factors and evaluation of the risk of 42. Hetland ML, Haarbo J, Christiansen C, et al. Running induces
osteoporosis in clinical practice. Ann Med Interne (Paris) menstrual disturbances but bone mass is unaffected, except in
2000; 151: 392-8 amenorrheic women. Am J Med 1993; 95: 53-60
24. Dwyer JT. Health aspects of vegetarian diets. Am J Clin Nutr 43. Prior JC, Vigna YM, Schechter MT, et al. Spinal bone loss and
1988; 48 Suppl.: 712-38 ovulatory disturbances. N Engl J Med 1990; 323: 1221-7
Adis International Limited. All rights reserved. Sports Med 2001; 31 (15)
1032 Cumming & Cumming
44. Winters KM, Adams WC, Meredith CN, et al. Bone density and 59. Haenggi W, Casez JP, Birkhaeuser MH, et al. Bone mineral
cyclic ovarian function in trained runners and active controls. density in young women with long-standing amenorrhea: lim-
Med Sci Sports Exerc 1996; 28 (7): 776-85 ited effect of hormone replacement therapy with ethinyl-
45. Fisher EC, Nelson ME, Frontera WR, et al. Bone mineral con- estradiol and desogestrel. Osteoporos Int 1994; 4: 99-103
tent and levels of gonadotropins and estrogens in amenorrheic 60. Klibanski A, Biller BM, Schoenfeld DA, et al. The effects of
running women. J Clin Endocrinol Metab 1986; 62: 1232-6 estrogen administration on trabecular bone loss in young women
46. Nelson ME, Fisher EC, Catsos PD, et al. Diet and bone status with anorexia nervosa. J Clin Endocrinol Metab 1995; 80:
in amenorrheic runners. Am J Clin Nutr 1986; 43: 910-6
898-904
47. Snead DB, Stubbs CC, Weltman JY, et al. Dietary patterns,
61. Seeman E, Szmukler GI, Formica C, et al. Osteoporosis in an-
eating behaviors, and bone mineral density in women runners.
Am J Clin Nutr 1992; 56: 705-11 orexia nervosa: the influence of peak bone density, bone loss,
48. Wilmore JH, Wambsgans KC, Brenner M, et al. Is there energy oral contraceptive use, and exercise. J Bone Miner Res 1992;
conservation in amenorrheic compared with eumenorrheic 7: 1467-74
distance runners? J Appl Physiol 1992; 72: 15-22 62. Hergenroeder AC, Smith EO, Shypallo R, et al. Bone mineral
49. Rebar RW, Cumming DC. Reproductive function in women changes in young women with hypothalamic amenorrhea treated
athletes. JAMA 1981; 246 (14): 1590 with oral contraceptives, medroxyprogesterone, or placebo
50. Schachter M, Shoham Z. Amenorrhea during the reproductive over 12 months. Am J Obstet Gynecol 1997; 176: 1017-25
years - is it safe? Fertil Steril 1994; 62 (1): 1-16 63. Cumming DC. Exercise-associated amenorrhea, low bone den-
51. Chen EC, Brzyski RG. Exercise and reproductive dysfunction. sity, and estrogen replacement therapy. Arch Intern Med 1996;
Fertil Steril 1999; 71 (1): 1-6 156: 2193-5
52. Dueck CA, Matt KS, Manore MM, et al. Treatment of athletic 64. De Cree C, Lewin R, Ostyn M. Suitability of cyproterone ace-
amenorrhea with a diet and training intervention program. Int tate in the treatment of osteoporosis associated with athletic
J Sport Nutr 1996; 6: 24-40 amenorrhea. Int J Sports Med 1988; 9: 187-92
53. Drinkwater BL, Nilson K, Ott S, et al. Bone mineral density
65. Gibson JH, Mitchell A, Reeve J, et al. Treatment of reduced
after resumption of menses in amenorrheic athletes. JAMA
1986; 256: 380-2 bone mineral density in athletic amenorrhea: a pilot study.
54. Jonnavithula S, Warren MP, Fox RP, et al. Bone density is com- Osteoporos Int 1999; 10: 284-9
promised in amenorrheic women despite return of menses: a 66. Prior JC, Vigna YM, Barr SI, et al. Cyclic medroxyprogesterone
2-year study. Obstet Gynecol 1993; 81: 669-74 treatment increases bone density: a controlled trial in active
55. Burkman RT, Collins JA, Greene RA. Current perspectives on women with menstrual cycle disturbances. Am J Med 1994;
benefits and risks of hormone replacement therapy. Am J Ob- 96: 521-30
stet Gynecol 2001 Aug; 185 (2 Suppl.): S13-23
56. Metka M, Holzer G, Heytmanek G, et al. Hypergonadotropic
Adis International Limited. All rights reserved. Sports Med 2001; 31 (15)
Available online at www.sciencedirect.com Current Opinion in
ScienceDirect
Abstract Introduction
Functional hypothalamic amenorrhea (FHA) is the most Functional hypothalamic amenorrhea (FHA) is a chronic
common cause of secondary amenorrhea in women of repro- endocrine disorder caused by a disturbance in the
ductive age. FHA is predominantly caused by stress, pulsatile secretion of hormones in the hypothalamus,
decreased caloric intake, excessive exercise, or a combination which in turn results in suppression of the hypothal-
thereof. These physical, psychological, and metabolic amicepituitaryeovarian axis. Inhibition of pulsatile
stressors cause aberration in the pulsatile release of gonadotropin-releasing hormone (GnRH) secretion in
gonadotropin-releasing hormone (GnRH) and subsequently the hypothalamus decreases follicle-stimulating hor-
impair function of the hypothalamic–pituitary–ovarian (HPO) mone (FSH) and luteinizing hormone (LH) secretion
axis. Various neurotransmitters acting in the central nervous from the pituitary gland. This sequence leads to the
system are involved in control of the HPO axis and of these, suppression of hormonal and reproductive functions of
kisspeptin is one of the most important. Corticotropin-releasing the ovary [1,2].
hormone (CRH), also inhibits the pulsatile secretion of GnRH
and also acts as an intermediary between stress factors and Secondary amenorrhea, which is characterized as amen-
the reproductive system. One of the main ongoing concerns in orrhea occurring in a previously menstruating woman, af-
patients with FHA is chronic hypoestrogenism, a condition, fects approximately 3%e5% of the mature female
which is associated with sexual dysfunction and infertility. It population. FHA is responsible for 25%e35% of secondary
may also lead to osteoporosis, and predispose to neurode- amenorrhea, making it the most common cause of sec-
generative and cardiovascular diseases.28 adolescent with ondary amenorrhea in our population [3]. FHA will
secondary amenorrhea. Treatment of stress management to negatively affect the health of women of childbearing age
secondary amenorrhea for adolescent with significacy p in a variety of ways. Chronic hypoestrogenism associated
=0.001 with this disease has a negative effect on the skeletal
system, cardiovascular system, nervous system, sexual
Addresses
1 function, and mental health. Beyond hypoestrogenism,
Department of Gynecological Endocrinology, Poznan University of
Medical Sciences, Poznan, Poland multiple other metabolic and neuroendocrine alterations
2
Appletree Medical Group, Ottawa, ON K1R 5C1, Canada presented in FHA affect bone homeostasis. For instance,
recent studies have shown direct, beneficial roles of
Corresponding author: Meczekalski, Blazej (blazejmeczekalski@ kisspeptin in bone physiology, therefore decreased
yahoo.com)
kisspeptin level can also impair bone health [4]. Further-
more, connection between decreased leptin and IGF-1,
Current Opinion in Pharmacology 2022, 67:102288 elevated ghrelin and cortisol level as endocrine media-
This review comes from a themed issue on Endocrine and metabolic
tors of bone loss in FHA is an object of ongoing research
diseases (2023) [5]. Moreover, disturbance in the secretion of gonado-
Edited by Stephanie Constantin and Ivana Bjelobaba
tropins results in significant impairment of reproductive
function due to concomitant anovulation [1,2].
For complete overview about the section, refer Endocrine and
metabolic diseases (2023)
Three main factors contribute to the development of
Available online 11 September 2022
FHA, namely: stress, excessive exercise, and decreased
https://doi.org/10.1016/j.coph.2022.102288 food intake. An overall decreased energetic balance
1471-4892/© 2022 The Author(s). Published by Elsevier Ltd. This is an causes dysregulation of hypothalamic nuclei, which in
open access article under the CC BY-NC-ND license (http:// turn disrupt the action of kisspeptin/neuro- kinin
creativecommons.org/licenses/by-nc-nd/4.0/).
B/dynorphin (KNDy) neurons. Decreased secretion of
kisspeptin, in turn, contributes to abnormal pulsatile
secretion of GnRH, eventually causing FHA. Variability in
susceptibility to inhibition of
hypothalamicepituitaryeovarian (HPO) axis by
www.sciencedirect.com Current Opinion in Psycofarm 2022, 67:102288
2 Endocrine and metabolic diseases (2023)
external factors in this population support the hy- expression in the hypothalamus. Long-term energy
pothesis of the genetic predisposition to FHA devel- constraint in sheep has shown to reduce KISS1 mRNA
opment. Mutations in genes regulating GnRH expression in both the arcuate nucleus (ARC) and the
ontogeny and action including KAL1, FGFR1, PROKR2, preoptic area (POA) compared to sheep with a neutral
GNRHR can contribute to individual sensitivity to energy balance [17e19].
stressor [6,7].
Kisspeptin is secreted in hypothalamic nuclei by kiss-
This article primarily focuses on correlation between peptin/neurokinin B/dynorphin neurons. KNDy neurons
stress and hormonal disturbances in patients with FHA as in the hypothalamus are named for their co-expression
nowadays there is a growing population living under of kisspeptin, neurokinin B (NKB) and dynorphin (DYN)
conditions of chronic stress. Notwithstanding excessive [20]. It is known that NKB and DYN play a crucial role
exercise and undernutrition are also pivotal factors that in regulating the secretion of kisspeptin, and
influence kisspeptin expression and function. subsequently in GnRH secretion [21]. Specifically, NKB
is responsible for stimulation of KNDy to secrete kiss-
Treatment of stress management to peptin and in turn the downstream induction of GnRH
secondary amenorrhea for adolescent release. In contrast, DYN neurons exert an inhibitory
The gene KISS1 (KISS1) encoding the KISS1 protein effect, suppressing kisspeptin secretion, and in turn
was first discovered in 1996 by a team from Hershey, suppressing GnRH pulsatility [22].
Pennsylvania and was identified as a metastasis sup-
pressor in human malignant melanoma [8]. The name of KNDy neurons, apart from NKB and Dyn receptors, also
the gene, KISS1, comes from the famous Hershey’s express estradiol a receptors (ERa) and progesterone
Kisses chocolate, which was also produced in the town of receptors (PR). This allows the KNDy neuron to act as a
Hershey. The KISS1 gene is located on chromosome central regulator of systemic feedback for the repro-
1q32 and has four exons, the first two untranslated. The ductive system [12]. Because of those receptors, ovarian
gene encodes a precursor protein composed of 145 steroids can modulate the expression of KISS1 at the
amino acids, which is then cut in the process of post- hypothalamic level. In turn, kisspeptin is responsible for
translational processing, for example, into 54-amino the pulsatile release of GnRH [20]. Kisspeptin exerts the
acid fragments. This first intermediary protein is called essential stimulatory action needed in order to evoke the
metastin. Further processing leads to the forma- tion of preovulatory LH peak [23], which is an essential
14, 13, and 10 amino acid peptides [9]. Metastin and component in ovulation. The action of kiss- peptin with
these shorter proteins collectively share an N-ter- minal regard to reproduction descends all the way to the level
domain truncated at variable lengths but preser- ving a of the ovary. Kisspeptin exerts its influence on processes
C-terminal sequence of Arg-Phe-NH2. This group of such as steroidogenesis, follicular matura- tion,
proteins is collectively referred to as kiss- peptins [10]. ovulation, and ovarian senescence [23]. Furtherstudies,
however, are required to fully elucidate all as- pects of
In 2001, KISS1 was identified as a ligand for the G the mechanisms by which kisspeptin is involved in the
protein-coupled receptor 54 (GPR54) protein which physiology of reproduction.
was first described in the rat brain and then in humans,
where it is referred to as KISS1R [11]. Upon binding to Changes at the level of KNDy neurons are responsible for
KISS1, KISS1R activates phospholipase C and stimu- the changes observed in menopause. Hypertrophy of
lates the synthesis of intracellular secondary messen- KNDy neurons in the infundibular nucleus has been
gers, inositol triphosphate and diacylglycerol [12]. observed in subjects following menopause. Up to a 30%
increase in the size of these KNDy neurons has been
KISS1-secreting neurons are found mainly in the observed. These changes are associated with a subse-
preoptic area and in the arcuate nucleus of the hypo- quent increase in the secretion of neurokinin B and
thalamus [13,14]. By stimulating the secretion of kisspeptin in the area [24].
GnRH, KISS1 stimulates the secretion of FSH and LH
from the pituitary gland. Mutations that inactivate the A similar change was observed in oophorectomized
KISS1 or KISS1R genes have been found to cause monkeys, which suggest that ovarian impairment and
hypogonadotropic hypogonadism, while activating mu- the loss of negative feedback by estrogen plays a key role
tations cause premature puberty [15,16]. in this phenomenon [24].
KISS1 is a single element of the neurohormonal puzzle LH pulses are synchronized with hot flashes in pre- and
responsible for the interaction between the reproduc- tive post-menopausal women. While an increase in serum LH
system and the energy status of the body. Animalstudies concentration in women after menopause is a marker
have shown that caloric restriction due to decreased food of KNDy neuron hyperactivity, it also indicates that
intake leads to a decrease in KISS1 elevated kisspeptin or neurokinin B levels may play
a crucial role in the development of vasomotor symptom circulation. Cortisol, the primary stress hormone, causes
(VMS) pathogenesis [25]. Additionally, decreases in a pleiotropic response in different tissues, including
KNDy neuronal activity was associated with a decrease in promoting catecholamine release, mobilization of
skin vasodilation. All these observations support the energy stores, maintaining energy supply, and main-
hypothesis that KNDy neurons participate in the gen- taining negative influence on the immune system.
eration of hot flashes [26]. Without exposure to stress factors, CRH and conse-
quently ACTH and cortisol are secreted in a circadian,
Stress: A biological and hormonal pulsating manner with peak output in the early morning
background hours. This harmonic, pulsatile pattern of hormone
Homeostasis was coined as a term in the early 1900s by secretion is disrupted when challenged by a stressor.
Walter B. Cannon, the pioneer of stress response theory. During an episode of stress, CRH secretion significantly
He characterized this new term as a state of steady in- increases to activate the whole HPA axis. Additionally,
ternal conditions. His work laid the foundation for future other stress mediators are also released to synchronously
study in which extended his theory to include conditions stimulate the HPA axis. Glucocorticoids act in a nega- tive
which he described as threats to homeo- feedback loop to control the basal activity of the HPA axis
stasisdstressors. Since this foundational work, under- and eventually to terminate the stress response,
standing the human body’s reaction to stress factors has preventing the negative catabolic effects of anelongated
been studied extensively. Exposure to stress initiates a exposure to glucocorticoids.
complex biological response which draws interaction
between nervous, endocrine, and immune systems [27]. The aim of these actions is to support essential organs so
Two major components of the stress-response system as to ensure survival.
are the hypothalamicepituitaryeadrenal (HPA) axis and
sympathetic nervous system, which function coop- Impact of stress on reproductive function Since
eratively in orchestrating the stress response [28]. the origin of the human species, stress has been an
integral part of everyday life, affecting many different
The sympathetic nervous system forms part of the systems of the human body, including the endocrine,
autonomic nervous system and is responsible for imme- nervous, and immune systems. Moreover, as
diate response to stress factors, a process, which is known reproductive function is not essential for survival and
as acute stress response. Activation of the sympathetic requires a large amount of energy, it is understandably
nervous system leads to the release of epinephrine and suppressed by stress factors. Early researchers had
norepinephrine from adrenal glands into the bloodstream found that different kinds of stress can cause imbalance
and increased secretion of norepinephrine from sympa- to reproductive homeostasis and consequently lead to
thetic neurons in the central nervous system. Catechol- infertility. The exact mechanism, however, by whichthis
amines interact with adrenergic receptors distributed aberrancy develops was unknown for many years. It was
throughout the body which causes a cascading fight-or- shown that stress-related factors such as
flight response reaction in end-organs. This fighteore corticotropin-releasing hormone and cortisol are in-
flight reaction manifests as bronchial dilatation, elevated hibitors of the hypothalamicepituitaryegonadal (HPG)
breathing rate, increased blood pressure and cardiac axis but the link to explain the underlying complex
output, and liberation of metabolic energy sources for use mechanism remained unknown. The discovery of kiss-
in muscular action. Moreover, behavioral changes will peptin and gonadotropin-inhibitory hormone (GnIH)
also occur in order to improve vigilance and prepare to was a monumental breakthrough in the early 21st
address potential threats. In contrast to that, the para- century. Further discovery of their role in controllingthe
sympathetic nervous system enables body recovery after HPG axis provided the missing element in under-
the stressor disappears. standing the exact mechanism of stress-induced
reproductive suppression and has since begun a new
The HPA axis is influenced by both central and pe- era in research on the subject.
ripheral branches of the stress system; therefore, its
precise functioning is crucial for efficacious reactions to Kisspeptin is a hypothalamic neuropeptide that appears
stress factors. The integrated HPA axis is responsible to be a key factor driving the HPG axis by direct stimu-
primarily for delayed stress response. The first step lation of GnRH neurons. In 2008, Iwasa et. all pioneered
in this response is the release of corticoliberin or corti- research which found that immune stress induced by
cotropin-releasing hormone (CRH) from the para- administration of lipopolysaccharides (LPS) decreased
ventricular nucleus of the hypothalamus to the the level of Kiss1 mRNA and subsequently LH concen-
hypophyseal portal system. CRH stimulates the anterior tration in the hypothalamus of female rats [29]. Further
lobe of the pituitary gland to release adrenocorticotropic studies reproduced the findings and further supported
hormone (ACTH), which will sequentially stimulate this theory by showing that a number of other stressors
secretion of glucocorticoids from the adrenal cortex into also reduce the expression of Kiss1 mRNA [30]. These
findings established a link between the HPA axis and the expressed on kisspeptin neurons located in the arcuate
reproductive system. Studies have since shown that both nucleus of the hypothalamus [36]. This finding suggests
peripheral administration of corticosterone or central that kisspeptin neurons may play a bridging role as
administration of corticotropin lead to suppression of intermediary between the HPA axis (stress response
kisspeptin neurons [31]. system) and the HPG axis (reproductive regulato-ry
system).
RFamide-related peptide 3 (RFRP-3) is postulated to be
a GnIH that acts to suppress synthesis and release of Kotani et al. [37] have reported that serum kisspeptin
GnRH and gonadotropins. Recently it has been shown levels in patients with lactational amenorrhea were
that exposure to both acute and chronic stress elevates found to be comparable to that in healthy women.
the expression of GnIH mRNA in the hypothalamus. This Bacaopoulou [38] observed a negative correlation be-
leads to dysregulation of the HPG axis and sup- pression tween peripheral kisspeptin levels and body mass index
of reproduction. Interestingly, glucocorticoste- roid (BMI) in anorectic patients. In this study, the authors
receptors have been found on the surface of GnIH found that amenorrheic adolescents tended to have a
neurons. During experimental trials it was found that, lower serum kisspeptin concentration, although this
when administered, corticosterone increases GnIH finding was not statistically significant. In cases of
mRNA expression and reduces GnRH activity [32]. This anorexia nervosa, serum kisspeptin levels have been
provides evidence that not only kisspeptin but also GnIH shown to correlate positively with body weight, body
contributes to mediation of the inhibitory effects of mass index, and fat mass.
corticosteroids on the human reproductive axis during
stressful events. In an interesting observation, Hoffman et al. [39] were
able to establish a negative correlation between serum
Undoubtedly, further studies are required to fully un- kisspeptin concentrations and physical activity. In their
derstand the complex neural interactions involved in the commentary, the authors suggested that this negative
modulation of reproductive function by stress. relationship may function as a compensatory mechanism
to prevent physical activity and body mass loss in
anorectic patients.
The role of kisspeptin in stress-related
amenorrhea KISS1 secreting neurons are believed to be in contact
As a key regulator of reproductive physiology, kiss- with the proopiomelanocortin as well as cocaine- and
peptin has a positive influence on the pulsatile secre- amphetamine-regulated transcript (POMC/CART)
tion of GnRH. It is because of this that understanding neurons and agouti-related peptide/neuropeptide Y
its role and function is invaluable when discussing (AgRP/NPY). This may be a potential route of
reproductive pathophysiology such as FHA [33]. The communication between systems in the hypothalamus
pulsatility and serum levels of kisspeptin as they relate to as both leptin and neuropeptide Y have been shown to
LH secretion was studied by Podfigurna et al. [34] in stimulate the expression of the KISS1 gene. It seems
more than 70 women with functional amenorrhea. It was unlikely, however, that the stimulating effect of leptin on
found that both hormones are co-secreted and serum KISS1-secreting neurons would occur through theaction
levels were temporally coupled. Additionally, a negative of NPY, since leptin directly inhibits the forma- tion of
correlation between the serum concentration and pulse NPY [40].
frequency of kisspeptin and serum levels of cortisol were
observed. This correlation, among other hormonal Other notable hormonal messengers acting between the
parameters, supports the hypothesis that stress-induced metabolic and kisspeptin systems are ghrelin, insulin- like
compensatory changes are the main direct and indirect growth factor-1 (IGF-1), and the hormones of the HPA
factors driving reproductive inhibi- tion in patients with axis [38]. Ghrelin, the secretion of which increases in
FHA. states of energy deficiency, suppresses the hypotha-
lamic expression of KISS1 mRNA [40]. In contrast, IGF-
Research published in 2020 revealed that patients with 1 has been shown to increase KISS1 mRNA expression
FHA were characterized by lower serum kisspeptin levels in the anteroventral periventricular nucleus (AVPV) in
at baseline as well as having higher serum CRH levels female rats [41]. IGF-1 receptor blockade, however, does
when compared to healthy controls [35]. not change the KISS1 concentration in the hypo- thalamic
nuclei [42].
Stress-related hypothalamic amenorrhea refers to the
complex interplay between the hypothal-
amicepituitaryeadrenal axis and the HPG axis. Potential use of kisspeptin in functional
Augmented CRH levels (during stress) can directly hypothalamic amenorrhea
inhibit the pulsatile secretion of GnRH. New data shows The main goal in the treatment of hypothalamic
that both CRH and glucocorticoid receptors are amenorrhea is the restoration of a normal menstrual
cycle with ovulatory function [43]. Ovulatory function Jayasena et al. conducted a second trial exploring the use
can be restored with ovulation induction, but the aims of of kisspeptin-54 in patients with hypothalamic
restoring the ovarian cycle are multipledfor metabolic amenorrhea specifically [48]. FHA patients were
function, bone protection as well as fertility. This administered subcutaneous kisspeptin-54 or saline
endpoint should be achieved by the elimination of those twice-weekly. Women in the treatment arm presented
causative factors (such as stress, weight loss, excessive significantly higher serum levels of FSH and LH after 2
exercise), which were initially responsible for the months of bi-weekly dosing than did women in the
development of an amenorrheic state. This approach, placebo arm. No significant side effects to treatment
however, is often very difficult to introduce in clinical were observed in participants under this administration
practice, as it requires enthusiastic patient participation schedule. Intravenous administration of kisspeptin
and their willingness to undertake a real lifestyle change. caused augmentation of LH pulsatility (3-fold increase
If the lifestyle interventions have not been successful, An in mean peak number of pulses) when compared to
Endocrine Society Clinical Practice Guideline placebo in all FHA patients [49]. Additionally, the mean
recommends that treatment with pulsatile serum levels of both FSH and estradiol were also
gonadotropin-releasing hormone should be considered significantly elevated during high-dose infusion of this
as first line treatment [44]. Pulsatile GnRH pump rep- peptide when compared with placebo. For the first time
resents a safer, more physiologic alternative to ovulation it was reported that constant intravenous kisspeptin-54
induction using injectable gonadotropins. Unfortu- administration may temporarily increase both basal and
nately, there is no commercially available GnRH pump pulsatile LH release in patients with HA. The study
in most countries; therefore, gonadotropin use for protocol also established a dose range within which
ovulation induction remains only obtainable treatment kisspeptin-54 therapy is able to restore LH secretion
in many cases. (both basal and pulsatile).
Hormonal replacement therapy can be initiated. Such Another milestone in the field of kisspeptin research
therapy, based not on traditional combined contracep- was reached in 2020 when for the first time a kisspeptin
tion but rather on that mimicking natural estrogen and receptor agonist was used therapeutically in patients
progestin with limited anti-gonadotropic action can also with FHA [50]. Abbara et al. demonstrated that serum
be introduced. Should a patient with FHA who is treated LH and FSH levels increased sooner after administra-
with such estrogeneprogestin therapy decidethey wish tion of KissR agonist in women with FHA than it did in
to become pregnant, initiating therapy with a GnRH healthy women. This new KISSR agonist MVT-602
pulsatile pump can be considered [45]. demonstrated many favorable properties, including
better stability, potency, and water solubility compared
In recent years, novel pharmacological approaches have to native Kisspeptin.
developed to treat patients with FHA. New and devel-
oping knowledge on the role of kisspeptin in the central Eye to the future
regulation of reproductive functions has allowed for the Kisspeptin as the main positive regulator of GnRH
development of kisspeptin as a possible therapeu-tic secretion plays an important role in the regulation of
tool. reproductive function. Continued research can further
elucidate new details in this pathway and expand our
Feasibility studies into the use of kisspeptin have been understanding of stress as a biological factor impacting
conducted in animal models. When administered, kiss- the HPG axis.
peptin provoked LH and FSH secretion in all mamma-
lian animals [46]. The first human trial of kisspeptin As a signaling bridge between the HPA and HPG axis,
administration in patients with functional hypothalamic kisspeptin pathophysiology requires further studies.
amenorrhea was reported by Jayasena et al., in 2009 Additionally, the most important yet challenging
[47]. An initial randomized controlled trial was con- endpoint is to establish the practicality of using kiss-
ducted to compare acute and chronic kisspeptin peptin in the treatment of patients with FHA. It is likely
administration and its effect on serum LH and FSH. After that novel and newly developed kisspeptin receptor
acute subcutaneous kisspeptin administration, a 10-fold agonists are on the horizon. It is thus imperative that
increase in LH secretion was observed while FSH efforts should be focused on carefully establishing the
secretion increased 2.5-fold. When administered safety and efficacy parameters of these new pharmaco-
chronically over 2. 28 adolescent with secondary logical tools.
amenorrhea. Treatment of stress management to
secondary amenorrhea for adolescent with significacy p Funding
=0.001 This research did not receive any specific grant from
funding agencies in the public, commercial, or not-for-
profit sectors.
Credit author statement 12. Skorupskaite K, George JT, Anderson RA: The kisspeptin-
GnRH pathway in human reproductive health and disease.
B.M.: Conceptualization, Investigation, Resources, Hum Reprod Update 2014, 20:485–500, https://doi.org/10.1093/
Writing e original draft, Supervision; A.SZ.: Investiga- humupd/dmu009.
tion, Writing e original draft O.N.: Investigation, Re- 13. Hrabovszky E: Neuroanatomy of the human hypothalamic
sources, Writing e original draft, Writing e review & kisspeptin system. Neuroendocrinology 2014, 99:33–48, https://
doi.org/10.1159/000356903.
editing; G.B.: Writing e review & editing. All authors
have read and agreed to the published version of the 14. Hrabovszky E, Ciofi P, Vida B, et al.: The kisspeptin system of
the human hypothalamus: sexual dimorphism and relation-
manuscript. ship with gonadotropin-releasing hormone and neurokinin B
neurons. Eur J Neurosci 2010, 31:1984–1998, https://doi.org/
10.1111/j.1460-9568.2010.07239.x.
Conflict of interest statement 15. Teles MG, Bianco SDC, Brito VN, et al.: A GPR54-activating
Nothing declared. mutation in a patient with central precocious puberty. N Engl
J Med 2008, 358:709–715, https://doi.org/10.1056/
References NEJMoa073443.
Papers of particular interest, published within the period of review, 16. de Roux N, Genin E, Carel J-C, Matsuda F, Chaussain J-L,
have been highlighted as: Milgrom E: Hypogonadotropic hypogonadism due to loss of
function of the KiSS1-derived peptide receptor GPR54. Proc
* of special interest Natl Acad Sci USA 2003, 100:10972–10976, https://doi.org/
10.1073/pnas.1834399100.
1. Lania A, Gianotti L, Gagliardi I, Bondanelli M, Vena W, 17. Backholer K, Smith JT, Rao A, et al.: Kisspeptin cells in the Ewe
Ambrosio MR: Functional hypothalamic and drug-induced brain respond to leptin and communicate with neuropeptide
amenorrhea: an overview. J Endocrinol Invest 2019, 42: Y and proopiomelanocortin cells. Endocrinology 2010, 151:
1001 –1010, https://doi.org/10.1007/s40618-019-01013-w. 2233 –2243, https://doi.org/10.1210/en.2009-1190.
2. Gordon CM, Ackerman KE, Berga SL, et al.: Functional hypo- 18. Wolfe A, Hussain MA: The emerging role(s) for kisspeptin in
thalamic amenorrhea: an endocrine society clinical practice metabolism in mammals. Front Endocrinol 2018, 9:184, https://
guideline. J Clin Endocrinol Metab. March 2017, https://doi.org/ doi.org/10.3389/fendo.2018.00184.
10.1210/jc.2017-00131.
19. Dudek M, Ziarniak K, Sliwowska JH: Kisspeptin and meta-
3. Nancy A: Curosh,Secondary amenorrhea. In Decision making bolism: the brain and beyond. Front Endocrinol 2018, 9:145,
in medicine(ThirdEdition). Edited by Mushlin Stuart B, https://doi.org/10.3389/fendo.2018.00145.
Greene Harry L, Mosby; 2010:582 –583, https://doi.org/10.1016/
B978-0-323-04107-2.50210-6. ISBN 9780323041072. 20. Cheng G, Coolen LM, Padmanabhan V, Goodman RL,
Lehman MN: The kisspeptin/neurokinin B/dynorphin (KNDy)
4. Mills EG, Yang L, Nielsen MF, Kassem M, Dhillo WS, cell population of the arcuate nucleus: sex differences and
Comninos AN: The relationship between bone and reproduc- effects of prenatal testosterone in sheep. Endocrinology 2010,
tive hormones beyond estrogens and androgens. Endocr Rev 151:301–311, https://doi.org/10.1210/en.2009-0541.
2021 Nov 16, 42:691–719, https://doi.org/10.1210/endrev/
bnab015. Erratum in: Endocr Rev. 2021 Oct 01;: PMID: 21. Navarro VM: Metabolic regulation of kisspeptin — the link
33901271; PMCID: PMC8599211. * between energy balance and reproduction. Nat Rev Endocrinol
2020, 16:407–420, https://doi.org/10.1038/s41574-020-0363-7.
5. Behary P, Comninos AN: Bone perspectives in functional hy- Authors described that kisspeptin neurons are the main conveyor of the
pothalamic amenorrhoea: an update and future avenues. current metabolic status of the organism to control the reproductive
Front Endocrinol 2022 Jun 20, 13:923791, https://doi.org/10.3389/ axis. Authors observed that activity of the kisspeptin neuron can be
fendo.2022.923791. PMID: 35795153; PMCID: PMC9251506. modulated by metabolic factors at subcellular, neuroendocrine and
endocrine levels.
6. Podfigurna Agnieszka, Meczekalski Blazej: Functional hypo-
thalamic amenorrhea: a stress-based disease. Endocrine 22. Skorupskaite K, George JT, Veldhuis JD, Millar RP,
2021, 2:203–211, https://doi.org/10.3390/endocrines2030020. Anderson RA: Interactions between Neurokinin B and kiss-
peptin in mediating estrogen feedback in healthy women.
7. Caronia LM, Martin C, Welt CK, Sykiotis GP, Quinton R,
J Clin Endocrinol Metab 2016, 101:4628 –4636, https://doi.org/
Thambundit A, Avbelj M, Dhruvakumar S, Plummer L, 10.1210/jc.2016-2132.
Hughes VA, Seminara SB, Boepple PA, Sidis Y, Crowley Jr WF,
Martin KA, Hall JE, Pitteloud N: A genetic basis for functional 23. Hu KL, Zhao H, Chang HM, Yu Y, Qiao J: Kisspeptin/kisspeptin
hypothalamic amenorrhea. N Engl J Med 2011 Jan 20, 364: receptor system in the ovary. Front Endocrinol 2018, 8:1,
215–225, https://doi.org/10.1056/NEJMoa0911064. PMID: https://doi.org/10.3389/fendo.2017.00365.
21247312; PMCID: PMC3045842.
24. Rance NE, McMullen N, Smialek JE, Price DL, Young WS:
8. Lee J-H, Miele ME, Hicks DJ, et al.: KiSS-1, a novel human Postmenopausal hypertrophy of neurons expressing the
malignant melanoma metastasis-suppressor gene. JNCI J Natl estrogen receptor gene in the human hypothalamus. J Clin
Cancer Inst 1996, 88:1731 –1737, https://doi.org/10.1093/ Endocrinol Metab 1990, 71:79–85, https://doi.org/10.1210/jcem-
jnci/88.23.1731. 71-1-79.
9. Ohtaki T, Shintani Y, Honda S, et al.: Metastasis suppressor 25. Jayasena CN, Comninos AN, Stefanopoulou E, et al.: Neurokinin
gene KiSS-1 encodes peptide ligand of a G-protein-coupled B administration induces hot flushes in women. Sci Rep 2015,
receptor. Nature 2001, 411:613–617, https://doi.org/10.1038/ 5:8466, https://doi.org/10.1038/srep08466.
35079135.
26. Rance NE, Dacks PA, Mittelman-Smith MA, Romanovsky AA,
10. Kotani M, Detheux M, Vandenbogaerde A, et al.: The metastasis Krajewski-Hall SJ: Modulation of body temperature and LH
suppressor gene KiSS-1 encodes kisspeptins, the natural li- secretion by hypothalamic KNDy (kisspeptin, neurokinin B
gands of the orphan G protein-coupled receptor GPR54. J Biol and dynorphin) neurons: a novel hypothesis on the mecha-
Chem 2001, 276:34631–34636, https://doi.org/10.1074/ nism of hot flushes. Front Neuroendocrinol 2013, 34:211–227,
jbc.M104847200. https://doi.org/10.1016/j.yfrne.2013.07.003.
11. Gottsch ML, Clifton DK, Steiner RA: From KISS1 to kisspeptins: 27. Mifsud KR, Reul JMHM: Mineralocorticoid and glucocorticoid
an historical perspective and suggested nomenclature. Pep- receptor-mediated control of genomic responses to stress in
tides 2009, 30(1):4 –9, https://doi.org/10.1016/ the brain. Stress 2018 Sep, 21:389–402, https://doi.org/10.1080/
j.peptides.2008.06.016. 10253890.2018.1456526. Epub 2018 Apr 4. PMID: 29614900.
28. Chu B, Marwaha K, Sanvictores T, et al.: Physiology, stress Endocrinol 2012, 8:40–53, https://doi.org/10.1038/
reaction. [Updated 2021 sep 18] [Internet]. In StatPearls. Stat- nrendo.2011.147.
Pearls Publishing; 2022 Jan. Available from:, https://www.ncbi.
nlm.nih.gov/books/NBK541120/?report=classi. 41. Todd BJ, Fraley GS, Peck AC, Schwartz GJ, Etgen AM: Central
insulin-like growth factor 1 receptors play distinct roles in the
29. Iwasa T, Matsuzaki T, Murakami M, et al.: Decreased expres- control of reproduction, food intake, and body weight in
sion of kisspeptin mediates acute immune/inflammatory female Rats1. Biol Reprod 2007, 77:492–503, https://doi.org/
stress-induced suppression of gonadotropin secretion in 10.1095/biolreprod.107.060434.
female rat. J Endocrinol Invest 2008, 31:656–659, https://doi.org/
10.1007/BF03345620. 42. Hiney JK, Srivastava VK, Pine MD, Les Dees W: Insulin-like
growth factor-I activates KiSS-1 gene expression in the brain
30. Hirano T, Kobayashi Y, Omotehara T, Tatsumi A, Hashimoto R, of the prepubertal female rat. Endocrinology 2009, 150: 376–
Umemura Y, Nagahara D, Mantani Y, Yokoyama T, Kitagawa H, 384, https://doi.org/10.1210/en.2008-0954.
Hoshi N: Unpredictable chronic stress-induced reproductive
suppression associated with the decrease of kisspeptin 43. Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A,
immunoreactivity in male mice. J Vet Med Sci 2014 Sep, 76: Maciejewska-Jeske M: Functional hypothalamic amenorrhea
1201–1208, https://doi.org/10.1292/jvms.14-0177. Epub 2014 and its influence on women’s health. J Endocrinol Invest 2014,
May 27. PMID: 24871549; PMCID: PMC4197145. 37. 1949-1056.
31. Luo E, Stephens SB, Chaing S, Munaganuru N, Kauffman AS, 44. Gordon Catherine M, Ackerman Kathryn E, Berga Sarah L,
et al.: Corticosterone blocks ovarian cyclicity and the LH Kaplan Jay R, George Mastorakos, Misra Madhusmita, Hassan
surge via decreased kisspeptin neuron activation in female Murad M, Santoro Nanette F, Warren Michelle P: Functional
hypothalamic amenorrhea: an endocrine society clinical
mice. Endocrinology 2016, 157:1187–1199. practice guideline. J Clin Endocrinol Metab 1 May 2017, 102:
32. Choi YJ, Habibi HR, Kil GS, Jung MM, Choi CY: Effect of cortisol 1413 –1439, https://doi.org/10.1210/jc.2017-00131.
on gonadotropin inhibitory hormone (GnIH) in the cinnamon
clownfish, Amphiprion melanopus. Biochem Biophys Res 45. Pape J, Herbison AE, Leeners B: Recovery of menses after
* functional hypothalamic amenorrhea: if when and why. Hum
Commun 2017, 485:342–348.
Reprod Update 2021, 27:130–153.
33. Trevisan CM, Montagna E, de Oliveira R, Christofolini DM, The authors studied potential physical and psychological mechanisms
Barbosa CP, Crandall KA, Bianco B: Kisspeptin/GPR54 System involved in the onset and end of FHA. Authors tried to establish if a
: what do we know about its role in human reproduction. Cell prediction model for when the menstrual cycle will recover in individual
Physiol Bochem 2018, 49:1259–1276. women will be achieved in the near future.
34. Podfigurna A, Maciejewska-Jeske M, Meczekalski B, 46. Thompson EL, Patterson M, Murphy KG, Smith KL, Dhillo WA,
Genazzani AD: Kisspeptin and LH pulsatility in patients with Todd JF, Ghatei MA, Bloom SR: Central and peripheral
functional hypothalamic amenorrhea. Endorcine 2020, 70: 635– administration of Kisspeptin-10 stimulates the Hypotha-
643. lamic -Pituitary-Gonadal axis. J Neuroendocrinol 2004, 16: 850–
858.
35. Podfigurna A, Szeliga A, Meczekalski B: Serum levels of kiss-
* peptin and corticotropin releasing hormone levels in patients 47. Jayasena CN, Nijher GM, Chaudhri OB, Murphy KG, Ranger A,
with functional hypothalamic amenorrhea. GREM , Gyneco- Lim A, Patel D, Mehta A, Todd C, Ramachandran R, Salem V,
logical and Reproductive Endocrinology and Metabolism 2020, 1: Stamp GW, Donaldson M, Ghatei MA, Bloom SR, Dhillo WS:
27–42. Subcutaneous injection of kisspeptin-54 acutely stimulates
The authors demonstrated the presence of a distinct kisspeptin gponadotropin secretion in women with hypothalamic
episodic secretion in patients with FHA and proved that though in amenorrhea, but chronic admisnitration causes tachyphy-
amenorrhea, the reproductive axis is still relying on kisspeptin to drive laxis. J Clin Endocrinol Metabol 2009, 94:4315–4323.
GnRH discharge in this group of patients.
48. Jayasena CN, Nijher GM, Abbara A, Murphy KG, Lim A, Patel D,
36. Ozawa H: Kisspeptin neurons as an integration center of Mehta A, Todd C, Donaldson M, Trew GH, Ghatei MA, Bloom SR,
* reproductive regulation : observation of reproductive func- Dhillo WS: Twice-weekly administration of kisspeptin-54 for 8
tions based on a new concept of reproductive regulatory weeks stimulates release of reproductive hormones in
nervous system. Reprod Med Biol 2021, 21, e12419. women with hypothalamic amenorrhea. Clin Pharmacol Ther
Authors investigated changes in kisspeptin neurons and associated 2010, 88:840–847.
changes in the hypothalamic–pituitary–gonadal axis under influence
of various direct and indirect environmental factors. 49. Jayasena CN, Abbara A, Veldhuis JD, Comninos AN,
Ratnasabapathy R, De Silva A, Nijher GM, Ganiyu-Dada Z,
37. Kotani M, Katagiri F, Hirai T, Kagawa J, Tanaka I: Plasma kiss- Mehta A, Todd C, Ghatei MA, Bloom SR, Dhillo WS: Increasing
peptin levels in lactational amenorrhea. Gynecol Endocrinol LH pulsatility in women with hypothalamic amenorrhea using
2017, 33:819–821. intravenous infusion of kisspeptin-54. J Clin Endocrinol Metab
2014, 99:E953–E961.
38. BacopoulouF, Lambrou GI, Rodanaki ME, Stergioti E,
Efthymiou V, Deligeoroglou E, Markantonis SL: Serum kiss- 50. Abbara A, Eng PC, Phylactou M, Clarke SA, Richardson R,
peptin concentrations are negativelu correlated with body * Sykes CM, Phumsatitpong C, Mills E, Modi M, Izzi-Engbeaya C,
mass indexin adolescents with anorexia nervosa and Papadopoulou D, Purugganan K, Jayasena CN, Webber L,
amenorreha. Hormones (Basel) 2017, 16:33–41. Salim R, Owen B, Bech P, Comninos AN, McArdle CA, Voliotis M,
Tsaneva-Atanasova K, Moenter S, Hanyaloglu A, Dhillo WS:
39. Hoffman T, Ebelt U, Haas V, Ahnis A, Klapp BF, Rose M, Kisspeptin receptor agonist has therapeutic potential for
Stengel A: Plasma kisspeptin and ghrelin levels are inde- female reproductive disorders. J Clin Invest 2020, 130: 6739–
pendently correlated with physical activity in patients with 6753.
anorexia nervosa. Appetite 2017, 108:141–150. The authors investigated the effects of a KISS1R agonist, MVT-602 in
women with reproductive disorders and identified it as therapeutic
40. Navarro VM, Tena-Sempere M: Neuroendocrine control by agent for the treatment of female reproductive disorders.
kisspeptins: role in metabolic regulation of fertility. Nat Rev
Abstract
Functional hypothalamic amenorrhea (FHA) is a common cause of amenorrhea in adolescent girls. It is often seen in the setting of
stress, weight loss, or excessive exercise. FHA is a diagnosis of exclusion. Patients with primary or secondary amenorrhea sh ould be
evaluated for other causes of amenorrhea before a diagnosis of FHA can be made. The evaluat ion typically consists of a thorough history
and physical examination as well as endocrinological and radiological investigations. FHA, if prolonged, can have significant impacts on
metabolic, bone, cardiovascular, mental, and reproductive health. Management often involves a multidisciplinary approach, with a focus
on lifestyle modification. Depending on the severity, pharmacologic therapy may also be considered. The aim of this paper is to present
to correlation effect stress management of function hypotalamus secondary managemen with significance p < 0.005 about 45 adolesncent
Keywords: Adolescent, diagnosis, functional, secondary amenorrhea, stress management
Address for Correspondence: Tania Dumont MD, University of Ottawa, Children’s Hospital of Eastern Ontario, Conflict of interest: None declared
Division of Gynecology, Ottawa, Canada Received: 05.11.2019
Phone: +1-613-737-7600 E-mail: tdumont@cheo.on.ca ORCID: orcid.org/0000-0003-4622-8900 Accepted: 14.11.2019
©Copyright 2020 by Turkish Pediatric Endocrinology and Diabetes Society
The Journal of Clinical Research in Pediatric Endocrinology published by Galenos Publishing House.
18
J Clin Res Pediatr Endocrinol Gibson MES et al.
2020;12(Suppl 1):18-27 Functional Hypothalamic Amenorrhea
maintain 90-110% of their ideal body weight (IBW) and who the prokineticin receptor 2 gene PROKR2, the GnRH receptor
do not meet diagnostic criteria for an eating disorder (15). gene GNRHR, and the Kallmann syndrome 1 sequence gene
IBW is calculated by the Devine formula [IBW (kg)=45.5 kg KAL1. Such mutations were not found in healthy controls
+ 2.3 kg for each inch over 5 feet] (16) or can be determined (32).
by standardized height and weight tables such as the
Regardless of the trigger for FHA, a common hypothesis
Metropolitan Life tables (17). Disordered eating is quite
is that an increase in corticotropin-releasing hormone (CRH),
common in adolescent girls. In a cross-sectional study of
in response to stress, suppresses GnRH pulsatility (10).
grade 10 girls, 4.1% of girls sampled met the criteria for
Patients with FHA have increased cortisol levels
secondary amenorrhea and 23% disclosed disordered eating.
(10,12,13,14,20,29,33), as well as blunted responses to the
Of the girls with amenorrhea, 40% reported fasting or
injection of human CRH (hCRH) (13,29,33). In addition, the
purging. Interestingly, body mass index (BMI) (BMI; kg/ m2)
neurotransmitter ƴ-aminobutyric acid has also been linked
was not significantly different between those who were
to suppression of GnRH (13). Thyroid hormone changes are
eumenorrheic or amenorrheic (18). Studies have shown that
also noted in FHA. Patients with FHA tend to have lower total
patients with FHA exhibit more cognitive restraint (19), drive
triiodothyronine (T3) and total thyroxine (T4) concentrations
for thinness (12,19,20,21), and purging behaviours (21,22)
compared to eumenorrheic controls. compared to eumenorrheic controls (11,34). However, their
concentrations of free T3 and T4 may remain intact due to
Excessive exercise has been linked to the development of lower affinity of thyroid binding globulin (34). Thyroid-
FHA (23,24). In one study, rates of secondary amenorrhea stimulating hormone (TSH) levels typically remain normal
were three times higher in athletes compared to controls, (11,14,34) and patients appear to be clinically euthyroid
with the highest rates seen in long distance runners (25). (34). Metabolic disturbances are also observed, with
Since the early 1990s, the Female Athlete Triad (FAT) has decreased leptin (8,12,14,19,35,36), decreased fasting
been used to describe athletes who also present with insulin (12,14,35), decreased insulin-like growth factor-1
disordered eating, osteoporosis, and amenorrhea (26). In (IGF-1) (8,12), increased fasting peptide YY (19), and
2017, the American College of Obstetricians and increased fasting ghrelin in patients with FHA (19,22). These
Gynecologists revised the definition of FAT to be more changes reflect the overall energy deficit in patients with
inclusive. The criteria are now: low energy availability with FHA.
or without disordered eating, menstrual dysfunction, and
low bone density (27). Though the menstrual dysfunction in
FAT is thought to be hypothalamic in nature, FAT differs from Diagnosis of FHA
FHA because athletes are not required to be amenorrheic to The diagnosis of FHA can be challenging in adolescents, as
meet criteria for FAT. Moreover, not all patients with FHA are this is commonly a time when the HPO axis is developing.
athletes or meet the criteria for FAT. However, primary amenorrhea should always be
Onset of amenorrhea can also be seen in the setting of stress investigated, as 98% of girls will achieve menarche bythe
(12,28,29,30). In a study of adolescent girls with FHA, age of 15 (37). Furthermore, 90% of menstrual cycles will
identified stressors included common life events such as range between 21-45 days, even in the first few post-
changing schools, newly engaging in sexual activity, and menarchal years (38), highlighting the importance of
breaking up with a boyfriend. Chronic illness of a family investigating secondary amenorrhea in this age group.As
member and the death of a friend were also observed.Lastly, FHA is a non-organic cause of amenorrhea, it is often
50% of the adolescents in this study described family conflict considered a diagnosis of exclusion. Table 1 summarizes the
(12). Patients with FHA have also been shown to copeless well vast differential diagnoses of amenorrhea, which should be
with stress, including their autonomic responses, compared taken into consideration.
to those with PCOS and eumenorrheic controls (31).
History: A pubertal history should include onset and timing of
Lastly, there may also be a genetic basis to the development breast and pubic hair development, as well as growth spurt. A
of FHA. One study identified six heterozygous gene detailed menstrual history should be obtained to characterize
mutations in patients with FHA that are shared among the type of amenorrhea and its onset. One should look for
patients who have congenital (idiopathic) hypogonadotropic possible triggers including stressful life events, disordered
hypogonadism, suggesting a possible vulnerability to the eating, weight loss (regardless of initial weight), or excessive
effects of stressors on the HPO axis. Mutations found exercise. Disordered eating can include avoidance of certain
involved the fibroblast growth factor receptor 1 gene FGFR, foods (typically foods high in fat, sugar, and calories),
restricting, and/or purging (self-induced vomiting, laxative
19
Gibson MES et al. J Clin Res Pediatr Endocrinol
Functional Hypothalamic Amenorrhea 2020;12(Suppl 1):18-27
Table 1. Stress Managemnet of Secondary Amenorrhea use, or compensatory exercising). A diet log can be helpful.
Constitutional delay If weight loss has been identified as a contributing factor, it
Hypothalamus is important to note the weight at which the patient became
Central nervous system lesion (hydrocephalus, tumor) amenorrheic and the tempo of the weight loss. Lastly, it is
Chronic medical illness important to inquire about how the weight loss was achieved,
Congenital hypogonadotropic hypogonadism (Kallman as well as how they feel about the weight loss, as this helps
syndrome) determine whether a formal eating disorder diagnosis should
FHA (stress, weight loss, disordered eating, exercise) be considered. The type of exercise should be noted, as well as
Pituitary the duration and intensity. Patients should be asked about their
Congenital hypogonadotropic hypogonadism past medical history, including chronic illness or malignancy.
Empty Sella syndrome A list of medications should be obtained, and previous or
Hyperprolactinemia current treatments with chemotherapy or radiation should
Iatrogenic (surgery, radiation) be noted. A sexual history, taken alone with the adolescent
Infarction (Sheehan syndrome) in complete privacy, should be obtained, including use of
Infiltrative disease contraceptives. On review of symptoms, patients should be
Medications (amphetamines, antidepressants, asked about possible associated symptoms in a head to toe
antihypertensives, antipsychotics, dopamine antagonists, approach. To reiterate, one should ask about possible triggers
contraceptives, opiates)
affecting the hypothalamus, such as stress, disordered
Neurofibromatosis
eating, weight loss, or excessive exercise. Headaches, visual
Trauma
disturbances, or galactorrhea could suggest the presence of a
Tumor or cyst
prolactinoma or another central nervous system disorder. A
Thyroid
history of anosmia could point to Kallman syndrome. Changes
Hyperthyroidism
in energy, temperature regulation, or bowel movement
Hypothyroidism
frequency could be related to an underlying thyroid disorder.
Adrenal
Patients should be asked about signs of hyperandrogenism,
Adrenal insufficiency
such as acne or hirsutism, as this could point to a diagnosis
Androgen-secreting tumor
of PCOS or late-onset congenital adrenal hyperplasia. More
CAH
significant virilization (clitoromegaly, severe hirsutism, voice
Cushing syndrome
changes) could point to an androgen secreting tumour of
Ovary
either adrenal or ovarian origin. Vasomotor symptoms such
Androgen-secreting tumor as hot flashes or night sweats could be indicative of primary
Gonadal agenesis or dysgenesis (ex. Turner syndrome, Swyer ovarian insufficiency (POI). Inquire about symptoms of
syndrome)
pregnancy, such as weight gain, nausea, fatigue, vomiting, or
Iatrogenic (surgery, radiation)
breast tenderness. Abdominal pain, either cyclic or chronic,
Medications (antiandrogens, contraceptives)
could indicate a possible Müllerian anomaly. Lastly, a
PCOS
thorough family history, including the menstrual history of
POI
the biological mother, should be obtained. ǫuestions about
Uterus
possible triggers and sexual history should be reserved for
Adhesions (Asherman syndrome)
the confidential portion of the interview. Commonly, the
Levonorgestrel IUS
“Home environment, Education and employment, Eating,
Müllerian anomaly
peer-related Activities, Drugs, Sexuality, Suicide/depression,
Pregnancy
and Safety from injury and violence-HEEADSSS” format is
Outflow tract
used (39).
Cervical agenesis
Cervical stenosis (acquired) Physical examination: The physical examination should
Imperforate hymen first begin with a general inspection of the patient’s well
Vaginal agenesis being. The patient’s height and weight should be measured
Vaginal septum (transverse) and plotted on growth curves that ideally have previously
CAH: congenital adrenal hyperplasia, PCOS: polycystic ovarian syndrome, been completed by the referring or primary care provider
POI: primary ovarian insufficiency, IUS: intrauterine system, FHA: functional in order to facilitate comparisons and trends. The BMI (kg/
hypothalamic amenorrhea, Ref. 1,3,6,41.
m2) should be calculated and plotted. Vital signs should
20
J Clin Res Pediatr Endocrinol Gibson MES et al.
2020;12(Suppl 1):18-27 Functional Hypothalamic Amenorrhea
include blood pressure and heart rate. Hypertension and A progesterone withdrawal challenge can be given to aid
tachycardia can be seen in hyperthyroidism or Cushing in the diagnosis. Five to 10 mg of medroxyprogesterone
syndrome, whereas hypotension and bradycardia can be acetate are given for five to 10 days, after which the patient
seen in hypothyroidism, adrenal insufficiency, and severe should experience a withdrawal bleed (41). A positive test
eating disorders. Look for stigmata of Turner syndrome is indicated by vaginal bleeding within two to seven days of
(low hairline, webbed neck, wide carrying angle, shield completing the course of progestin (6). A negative test, or a
chest, and nevi, including facial nevi). Look for signs of lack of bleeding, may suggest an outflow tract abnormality
restrictive or purging behaviours, which include cachexia, or a hypoestrogenic state, as estrogen is responsible for
erosion of dental enamel, parotid gland swelling, vellus thickening the endometrial lining (43). Scant withdrawal
hair, Russell’s sign (calluses on the knuckles) and bleeding or spotting suggests marginal levels of endogenous
hypercarotenemia (yellowing of the skin). A visual field estrogen production (6). Unfortunately, experts caution
examination and fundoscopy is recommended, routine use of the progesterone withdrawal challenge,as
particularly if there are concerns regarding central it may be unreliable in determining the degree of
nervous system symptoms in the history. Palpate the estrogenization as this test is associated with false negative
thyroid gland for a goiter or nodules and examine for withdrawals (1,3,43,44).
other signs of thyroid disease (exophthalmos or proptosis, Radiological investigations: An ultrasound of the pelvis is
lid lag, hair or nail changes). Palpate the abdomen for helpful to identify the presence of a uterus and ovaries, and
masses. Look for signs of insulin resistance (acanthosis to rule out an adnexal mass. If a Müllerian anomaly is
nigricans), hyperandrogenism (acne or hirsutism), or suspected, magnetic resonance imaging (MRI) of the pelvis,
virilization (male pattern hair loss, change in muscle mass or a 3D transvaginal ultrasound, if the patient is coitarchal,
distribution, clitoromegaly, or voice deepening). Complete may better characterize the specific anomaly (45,46,47).
Tanner staging should be done to document pubertal Head imaging with computed tomography or MRI is not
development (40). The papilla and surrounding breastmay typically required unless the adolescent girl presents with
also be examined for residual signs of galactorrhea. galactorrhea (+/- hyperprolactinemia), headaches or visual
Perform an external genital examination with the aid of disturbances, suggesting a possible intracranial lesion
labial traction to assess for a patent hymen and lower (1,41,48). It may also be indicated if there is a negative
vagina. This examination can also aid in determining the progesterone withdrawal challenge (4).
extent of estrogenization of the vulva. Typically, a
reddened and thin hymen is seen in an estrogen-deficient Due to the risk of osteopenia and osteoporosis associated
state, whereas a light pink and plumper hymen is seen in with hypoestrogenism, patients with prolonged amenorrhea,
of six months or more, should be considered for baseline
the presence of adequate estrogen levels. The presence
bone mineral density (BMD) assessment measured by
of leukorrhea can also point to adequate estrogenization.
dual-energy X-ray absorptiometry (DEXA/DXA) scan and
Lastly, a bimanual examination can be performed in
lateral spine radiograph to assess for asymptomatic
patients who are sexually active, to palpate for a uterus
vertebral fractures (15,41,49,50,51,52,53). In adolescents,
and to rule out an adnexal mass. Typically, patients with
FHA will have a physical examination within normal limits. Table 2. Typical hormone pattern in functional
hypothalamic amenorrhea
Endocrinological investigations: Initial blood work-up
Hormone Level
should include measurement of the beta subunit of human
chorionic gonadotropin concentration, regardless of the Pituitary
disclosed sexual history, to rule out pregnancy. FSH, LH, FSH Low
estradiol, prolactin, and TSH concentrations should also be LH Low
measured routinely. If there are signs of hyperandrogenism TSH Low-Normal
on examination, an androgen panel should be ordered, PRL Normal
including total and free testosterone, androstenedione, and Ovarian
dehydroepiandrosterone sulfate, along with a 17- Estradiol Low
hydroxyprogesterone concentration, preferably in the early Testosterone Low-Normal
morning (1,3,41). Assessment of cortisol status may also be AMH Normal
considered, based on presenting features. See Table 2 for a FSH: follicle stimulating hormone, LH: luteinizing hormone, TSH: thyroid-
summary of laboratory findings in FHA. stimulating hormone, PRL: prolactin, AMH: anti-Müllerian hormone,
Ref. 11,12,13,14,41,42.
21
Gibson MES et al. J Clin Res Pediatr Endocrinol
Functional Hypothalamic Amenorrhea 2020;12(Suppl 1):18-27
BMD Z-scores are used as these values are adjusted for age improve BMD in patients with FHA. This recommendation
and gender. They must also be further interpreted in relation is based on two small studies (57,58). In a study by Kopp-
to the patient’s body size, ethnicity, and pubertal staging or Woodroffe et al (57), three out of four amenorrheic
skeletal maturity (defined by bone age) (53). There is no participants resumed menses after a 20-week program. The
absolute BMD Z-score threshold that can be used alone to program involved incorporating one rest day per week and
define osteoporosis. Rather, a diagnosis of osteoporosis a nutritional supplement to improve overall energy balance.
requires the presence of both a clinically significant fracture In another study by Lindberg et al (58), four out of seven
history (≥3 long bone fractures at any age up to 19 years old) amenorrheic participants in a 15-month program resumed
and a BMD Z-score <-2.0. However,a BMD Z-score >-2.0 does menses and had a small, statistically significant increasein
not to preclude the possibility of skeletal fragility, and in the BMD. Their program included a reduction in exercise
setting of a low-trauma vertebralfracture, there is no BMD Z- duration and calcium supplementation. Larger prospective
score requirement to make a diagnosis of osteoporosis (54). studies would be beneficial in confirming these results.
Evaluation of the BMD Z-score trajectory, based on serial
Specifically in amenorrheic female athletes, a
measurements over time, provides valuable information
multidisciplinary approach, which includes nutritional
about which patients are at risk for fractures (declining BMD
therapy, psychological therapy, and modification of exercise
Z-scores), versus those who may be showing signs of
regimen has been recommended (59,60).
recovery (53). BMD should be repeated every six to 12
months to assess for trajectory of BMD Z-score, in patients In all patients with FHA, if lifestyle modification is the
where risk factors remain present. Spine radiographs should primary treatment modality, a follow up should be done
also be monitored at a similar interval to assess for every two to three months to determine whether the desired
asymptomatic vertebral fracture (or immediately if effect is being achieved (60).
symptomatic), particularly if there is decline in BMD Z-score Psychological therapy: Adolescent girls and young adult
(53). women with FHA have been shown to cope less well with
Other investigations: A karyotype should be performed if stress (31), and are also at a higher risk of depression (50).
a chromosomal abnormality, such as Turner syndrome is In the study by Kondoh et al (29), patients with FHA related
suspected and/or if gonadotropins are elevated. If to psychogenic stress, aged 15-33, were treated with
gonadotropins are elevated and POI is diagnosed, other psychoeducation which focused on stress management. A
testing would be required including autoimmune antibodies greater proportion of these patients recovered compared
and Fragile X testing. to those with weight-associated FHA; 81.8% versus 54.0%.
Their average time to recovery was also slightly shorterat
17.2±4.1 months versus 19.4±5.0 months. A small
Stress Management
randomized controlled trial (RCT) looked at the effect of a
The menstrual cycle has been recognized as an important 20-week intervention with cognitive based therapy (CBT)
vital sign in adolescent girls (55,56), and the absenceof in patients with FHA (61). In this study, the eight patients
menses may be an indication of compromised overall health. randomized to the CBT arm had a higher rate of ovarian
As such, the main goal of management in FHA is the activity (87.5%) compared to those eight patients that were
resumption of menses. correlation effect stress in the observation arm (25.0%). Ovarian activity was
management of function hypotalamus secondary determined by measuring plasma estradiol and
managemen with significance p < 0.005 about 45 progesterone levels, in order to confirm ovulation. BMI did
adolesncent not significantly change during the intervention. CBT has also
been shown to have an impact on metabolic health in these
Lifestyle modification: Addressing possible triggers such as
patients. In a follow-up study by Michopoulos et al (62),
weight loss, disordered eating, or excessive exercise isa
patients randomized to the CBT arm had an improvement in
primary focus in the management of FHA. In one studyby
cortisol, TSH, and leptin concentrations compared to those
Kondoh et al (29), patients with FHA related to weight loss
in the observation arm.
were treated by a nutritionist for at least six months. 54.0%
of these patients resumed menses with an average recovery Other forms of psychological therapy have been studied. In
time of 19.4±5.0 months. to resume menses. A common a small prospective study, 12 patients with FHA, aged 20-33,
recommendation in the literature is thata 1-2 kg weight gain were given a 45-70 minute hypnotherapy session and then
from current weight, or a 5% increasein body weight, can observed for 12 weeks (63). Nine patients (75%) resumed
result in the resumption of menses and menses, and one patient became pregnant during this time.
22
J Clin Res Pediatr Endocrinol Gibson MES et al.
2020;12(Suppl 1):18-27 Functional Hypothalamic Amenorrhea
All patients also reported increased general well-being and been successful with lifestyle modification, and who arenot
improved self confidence. in need of COCs for contraception (41).
Though studies looking at psychological therapy in FHA have To date, the majority of evidence for the positive effects
been small, the effects of therapy are promising and are of transdermal estrogen on BMD comes from research
unlikely to result in harm. Therefore, psychological therapy involving patients with anorexia nervosa (77,78). However,
may be considered as part of the multidisciplinary treatment its use in patients with FHA is attracting interest and has
of patients with FHA. started to be studied. Zanker et al (76) published a case
report of a 24-year-old amenorrheic athlete, whom they
Pharmacological therapy: The main role of pharmacological
followed for 12 years. They measured her body weight every
therapy in FHA is to promote bone health and prevent the
three months and her BMD by DXA every 11-13 months.
development of osteoporosis. A lack of estrogen during
After being on COCs for five years, the BMD of her lumbar
premenopausal years has been linked to decreased BMD.
spine and proximal femur declined by 9.8% and 12.1%,
This is based on studies looking at the outcomes of
respectively. Her weight dropped concomitantly from 45.1
premenopausal women undergoing bilateral oophorectomy
to 41.4 kg. Over the next 3.7 years, she was treated with
(64,65). In one study, vertebral bone loss could be detected
transdermal estrogen and an oral progestin. Her lumbar
as early as six months post-operatively (64). An increase in
spine BMD gradually increased by 9.4%, despite a further
the frequency of fragility fractures of the radius and femoral
0.8 kg decline of body mass. In the last 2.9 years of the study,
neck was also observed (65). Similarly, in patients with FHA,
she continued the transdermal estrogen, gained a total of 8.1
the associated hypoestrogenic state can result in reduced
kg of body mass, and had a 16.9% increase in her proximal
bone density (15,50,51). In young women less than 20 years
femur BMD. Furthermore, an RCT by Ackerman et al. (79)
of age, missing even 50% of menstrual cycles can result in
from 2019 showed an improvement in BMD in athletes with
a significant decrease in BMD (52). Therefore, studies have
oligo-amenorrhea receiving transdermal estrogen. In this
looked at the effects of hormone replacement therapy on
study, 43 patients were randomized to receive a 100 mcg
BMD in patients with FHA.
17-estradiol transdermal patch twice weekly with cyclic
A systematic review by Liu and Lebrun (66) summarized micronized progesterone (200 mg, 12 days per month), 40
ten studies evaluating the impact of hormone therapy patients to receive a daily pill with 30 µg EE + 0.15mg
on BMD in women with FHA. They found seven studies desogestrel, and 38 patients received no hormonal
which demonstrated a positive effect of combined oral treatment. All patients also received 800 IU of vitamin D
contraceptives (COCs) on BMD (67,68,69,70,71,72,73), and ≥1200 mg of calcium per day. BMD was assessed at
two studies that showed no effect (74,75), and one case baseline, six, and 12 months. Patients randomized to the
report where a negative effect was observed (76). Of the patch arm had significantly higher spine and femoral neck
studies that showed a positive effect, two were small RCTs BMD Z-scores at 12 months compared to the pill and the no
(67,68). Hergenroeder et al (67) showed a significant treatment arm, and higher hip BMD Z-scores than the pill
increase in both the total BMD and lumbar spine BMD of arm. The results of this landmark study are promising and
five patients receiving 35 µg ethinyl estradiol (EE) + 0.5- lend support to the use of transdermal estrogen in patients
1 mg norethindrone, compared to five controls. Castelo- with FHA.
Branco et al (68) showed a significant increase in lumbar
In amenorrheic adolescents, 1200-1500 mg of calcium
spine BMD in 24 patients taking 30 µg EE + 0.15 mg
supplementation (80) as well as vitamin D 400-1000 IU (1)
desogestrel and 22 patients taking 20 µg EE + 0.15 mg
are recommended daily to support bone health. However,
desogestrel, compared to 18 control patients who showed
other therapies such as testosterone or bisphosphonates are
a decrease in BMD. Of the studies that showed no effect,
not currently recommended to improve BMD in patients
one cohort study looking at female long distance runners,
with FHA (41,81), as the literature available focuses mainly
found no difference in BMD after one year in nine patients
on patients with anorexia nervosa and the current evidence
who started on a COC (75). However, in the same study 11
is limited.
patients with FHA who were not using a COC showeda
significant reduction in BMD over the same time period. Fertility: Patients with FHA may experience escape ovulation
Currently, the Endocrine Society has recommended and therefore contraception is important if they do not
against using COCs for the sole purpose of improvingBMD, desire pregnancy (41). In addition, adolescents with FHA may
due to conflicting evidence. Instead, a trial of short-term inquire about future fertility. Ovarian reserve is typically
transdermal estrogen with a cyclic oral progestin is normal in these patients, as evidenced by theirnormal anti-
recommended in amenorrheic adolescents who have not Müllerian hormone (AMH) levels (42). In
23
Gibson MES et al. J Clin Res Pediatr Endocrinol
Functional Hypothalamic Amenorrhea 2020;12(Suppl 1):18-27
patients who desire pregnancy, ovulation induction with cardiovascular health of patients with FHA focus on the
pulsatile GnRH is the current gold standard (82,83,84,85). lifestyle modifications that can be made to resume
When compared to injectable gonadotropins, chances of menses (90).
conception are higher after six cycles of pulsatile GnRH at Novel therapies: Studies are now focusing on the underlying
96% versus 72% for injected gonadotropins based on life metabolic abnormalities within FHA to direct therapy. Small
table analysis (82). Furthermore, injectable gonadotropins RCTs have looked at the effects of treatment with
are associated with a higher rate of multiples (14.8% versus recombinant human leptin. Welt et al (94) demonstrated an
9.3%), though the finding was not statistically significant improvement in serum estradiol, increased levels of free T4,
(82). These results were more recently replicated in a study and IGF-1 with administration of recombinant methionyl
by Dumont et al (84) which showed a per patient conception human leptin (r-metHuLeptin; starting dose 0.08 mg per
rate of 65.8% with pulsatile GnRH versus 23.5% with kilogram of body weight per day) subcutaneously for two to
gonadotropins. Though the trend favouring pulsatile GnRH is three months. Three out of eight women (37.5%) resumed
the same in both studies, the conception rates in the Dumont ovulatory cycles, which the authors stated was higher than
et al study are significantly lower. This may be explained by the expected rate of spontaneous ovulation of 10%. In a
the differences in study populations between these studies, small RCT, recombinant human leptin (metreleptin; starting
with lower BMI and baseline gonadotropin levels in the dose 0.08 mg per kg of body weight per day) administered
Dumont et al (84) study. The mean BMI in Dumont et al was subcutaneously over 36 weeks, increased estradiol levels and
18.5 kg/m2 (pulsatile GnRH group) and 18 kg/m2 decreased cortisol levels compared to placebo (95). Patients
(gonadotropin group), whereas in Martin et al (82)it was 24.3 receiving recombinant human leptin in this study were also
kg/m2 (pulsatile GnRH group) and 24.5 kg/m2 (gonadotropin more likely to resume menses compared to controls (70%
group). Baseline LH, FSH, and estradiol levels were also lower versus 22.2%). In both studies, markers of bone formation
in Dumont et al (84). Naltrexone, an opioid antagonist, has were also found to be increased, though BMD did not change
also been studied. GnRH secretion has been found to be significantly (94,95). The administration of kisspeptin has
suppressed by endogenous opioids (86). It was also been studied, and while acute administration appears to
hypothesized that GnRH pulsatility could therefore be stimulate release of LH and FSH, chronic administration
stimulated by opioid antagonism. Though naltrexone has results in tachyphylaxis. Thus, the authors concluded that
been shown to increase GnRH pulsatility and increase rates acute administration of kisspeptin may have therapeutic
of ovulation (86,87,88,89), its use has not become standard potential in patients with FHA (96). The Endocrine Society
practice. has recommended against the use of leptin or kisspeptin in
the management of patients with FHA, as more research is
Cardiovascular considerations: Patients with prolonged
needed in this area (41).
FHA may be at higher risk of cardiovascular complications
in the future (90). Studies in pre-menopausal adult
women have shown hypothalamic hypoestrogenism is Conclusion
associated with a higher risk of coronary artery disease FHA is a common cause of both primary and secondary
(91). Other possible effects include vascular endothelial amenorrhea in adolescent girls. Common triggers include
dysfunction and reduced regional blood flow, as was stress, weight loss, and excessive exercise. As FHA is a
shown in young amenorrheic athletes (92). These athletes diagnosis of exclusion, a comprehensive workup should be
were also found to have abnormal lipid profiles, including performed to rule out anatomic and organic causes of
elevated total cholesterol and low-density lipoprotein amenorrhea. Prolonged FHA can have negative
cholesterol (92). As a follow-up study, Rickenlund et al (93) consequences on many aspects of a young women’s health,
investigated the effects of using a COC (30 µg EE + 0.15 including metabolic, bone, cardiovascular, mental, and
mg levonorgestrel) on these cardiovascular endpoints in reproductive implications. The main goal in these patients
amenorrheic athletes. While an improvement in vascular is the resumption of menses. Lifestyle modifications are the
endothelial function after nine months of COC use was first line focus for adolescent girls with FHA and a
found, the lipid profile did not significantly change, with multidisciplinary approach, including a pediatric gynecologist
the exception of a small increase in high-density and/or endocrinologist, pediatric sport psychologist, and
lipoprotein cholesterol. As this study was small, the sport dietician is beneficial. Pharmacological therapy can
authors indicated the need for larger, long-term studies to be considered in order to promote bone health, with
determine the clinical importance of their findings. As of transdermal estrogen being a promising option for patients.
now, the majority of recommendations surrounding Further research on novel agents, such as recombinant
24
J Clin Res Pediatr Endocrinol Gibson MES et al.
2020;12(Suppl 1):18-27 Functional Hypothalamic Amenorrhea
human leptin and kisspeptin, is required before considering 15. Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S,
Herzog D, Klibanski A. Severity of osteopenia in estrogen-deficient
their routine use in patients with FHA.
women with anorexia nervosa and hypothalamic amenorrhea. J Clin
Endocrinol Metab 1999;84:2049-2055.
Ethics
16. Devine B. Gentamicin therapy. Drug Intell Clin Pharm 1974;8:650-655.
Peer-review: Internally peer-reviewed. 17. No authors listed. 1983 metropolitan height and weight tables. Stat Bull
Metrop Life Found 1983;64:3-9.
Authorship Contributions 18. Selzer R, Caust J, Hibbert M, Bowes G, Patton G. The association
Literature Search: Marie Eve Sophie Gibson, Writing: Marie between secondary amenorrhea and common eating disordered
weight control practices in an adolescent population. J Adolesc Health
Eve Sophie Gibson, Nathalie Fleming, Caroline Zuijdwijk, 1996;19:56-61.
Tania Dumont. 19. Scheid JL, Williams NI, West SL, VanHeest JL, De Souza MJ. Elevated
PYY is associated with energy deficiency and indices of subclinical
Financial Disclosure: The authors declared that this study
disordered eating in exercising women with hypothalamic amenorrhea.
received no financial support. Appetite 2009;52:184-192. Epub 2008 Sep 25
20. Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-
References metabolic aberrations in women with functional hypothalamic
amenorrhea. J Clin Endocrinol Metab 1998;83:25-32.
1. Gordon CM. Clinical practice. Functional hypothalamic amenorrhea. N 21. Marcus MD, Loucks TL, Berga SL. Psychological correlates of functional
Engl J Med 2010;363:365-371. hypothalamic amenorrhea. Fertil Steril 2001;76:310-316.
2. Meczekalski B, Podfigurna-Stopa A, Warenik-Szymankiewicz A, 22. Schneider LF, Warren MP. Functional hypothalamic amenorrhea is
Genazzani AR. Functional hypothalamic amenorrhea: Current view on associated with elevated ghrelin and disordered eating. Fertil Steril
neuroendocrine aberrations. Gynecol Endocrinol 2008;24:4-11. 2006;86:1744-1749. Epub 2006 Oct 30
3. Klein DA, Poth MA. Amenorrhea: An approach to diagnosis and 23. Ackerman KE, Misra M. Bone health and the Female Athlete Triad in
management. Am Fam Physician 2013;87:781-788. adolescent athletes. Phys Sportsmed 2011;39:131-141.
4. Emans SJ, Laufer MR. Pediatric & Adolescent Gynecology. 6th ed. 24. Warren MP, Chua AT. Exercise-induced amenorrhea and bone health in
Philadelphia, Pa: Lippincott Williams & Wilkins; 2012. the adolescent athlete. Ann N Y Acad Sci 2008;1135:244-252.
5. Rosenfield RL. Clinical review: Adolescent anovulation: Maturational 25. Dusek T. Influence of high intensity training on menstrual cycle
mechanisms and implications. J Clin Endocrinol Metab 2013;98:3572- disorders in athletes. Croat Med J 2001;42:79-82.
3583. Epub 2013 Aug 2
26. Yeager KK, Agostini R, Nattiv A, Drinkwater B. The female athlete
6. Speroff L, Fritz M. Clinical Gynecologic Endocrinology and Infertility. triad: Disordered eating, amenorrhea, osteoporosis. Med Sci Sports
7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2005;401-464. Exerc 1993;25:775-777.
7. Golden NH, Carlson JL. The pathophysiology of amenorrhea in the 27. Committee on Adolescent Health Care. Committee Opinion No.702:
adolescent. Ann N Y Acad Sci 2008;1135:163-178. Female Athlete Triad. Obstet Gynecol 2017;129:160-167.
8. Couzinet B, Young J, Brailly S, Le Bouc Y, Chanson P, Schaison G. 28. Brown E, Bain J, Lerner P, Shaul D. Psychological, hormonal, and weight
Functional hypothalamic amenorrhoea: a partial and reversible disturbances in functional amenorrhea. Can J Psychiatry 1983;28:624-
gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 628.
1999;50:229-235.
29. Kondoh Y, Uemura T, Murase M, Yokoi N, Ishikawa M, Hirahara F.
9. Perkins RB, Hall JE, Martin KA. Neuroendocrine abnormalities in A longitudinal study of disturbances of the hypothalamic-pituitary-
hypothalamic amenorrhea: spectrum, stability, and response to adrenal axis in women with progestin-negative functional hypothalamic
neurotransmitter modulation. J Clin Endocrinol Metab 1999;84:1905- amenorrhea. Fertil Steril 2001;76:748-752.
1911.
30. Facchinetti F, Fava M, Fioroni L, Genazzani AD, Genazzani AR. Stressful
10. Suh BY, Liu JH, Berga SL, ǫuiqley ME, Laughlin GA, Yen SS. life events and affective disorders inhibit pulsatile LH secretion in
Hypercortisolism in patients with functional hypothalamic- hypothalamic amenorrhea. Psychoneuroendocrinology 1993;18:397-404.
amenorrhea. J Clin Endocrinol Metab 1988;66:733-739. 31. Gallinelli A, Matteo ML, Volpe A, Facchinetti F. Autonomic and
11. Berga SL, Mortola JF, Girton L, Suh B, Laughlin G, Pham P, Yen SS. neuroendocrine responses to stress in patients with functional
Neuroendocrine aberrations in women with functional hypothalamic hypothalamic secondary amenorrhea. Fertil Steril 2000;73:812-816.
amenorrhea. J Clin Endocrinol Metab 1989;68:301-308. 32. Caronia LM, Martin C, Welt CK, Sykiotis GP, ǫuinton R, Thambundit
12. Bomba M, Gambera A, Bonini L, Peroni M, Neri F, Scagliola P, Nacinovich A, Avbelj M, Dhruvakumar S, Plummer L, Hughes VA, Seminara SB,
R. Endocrine profiles and neuropsychologic correlates of functional Boepple PA, Sidis Y, Crowley WF Jr, Martin KA, Hall JE, Pitteloud N. A
hypothalamic amenorrhea in adolescents. Fertil Steril 2007;87:876-885. genetic basis for functional hypothalamic amenorrhea. N Engl J Med
Epub 2007 Jan 31 2011;364:215-225.
13. Meczekalski B, Tonetti A, Monteleone P, Bernardi F, Luisi S, Stomati M, Luisi 33. Nappi RE, Petraglia F, Genazzani AD, D’Ambrogio G, Zara C, Genazzani
M, Petraglia F, Genazzani AR. Hypothalamic amenorrhea with normal body AR. Hypothalamic amenorrhea: evidence for a central derangement
weight: ACTH, allopregnanolone and cortisol responses to corticotropin- of hypothalamic-pituitary-adrenal cortex axis activity. Fertil Steril
releasing hormone test. Eur J Endocrinol 2000;142:280-285. 1993;59:571-576.
14. Andrico S, Gambera A, Specchia C, Pellegrini C, Falsetti L, Sartori 34. Dominguez CE, Laughlin GA, Nelson JC, Yen SS. Altered binding ofserum
E. Leptin in functional hypothalamic amenorrhoea. Hum Reprod thyroid hormone to thyroxine-binding globulin in women with
2002;17:2043-2048. functional hypothalamic amenorrhea. Fertil Steril 1997;68:992-996.
25
Gibson MES et al. J Clin Res Pediatr Endocrinol
Functional Hypothalamic Amenorrhea 2020;12(Suppl 1):18-27
35. Miller KK, Parulekar MS, Schoenfeld E, Anderson E, Hubbard J, Klibanski 53. Ward LM, Konji VN, Ma J. The management of osteoporosis in children.
A, Garinspoon SK. Decreased leptin levels in normal weight women Osteoporos Int 2016;27:2147-2179. Epub 2016 Apr 28
with hypothalamic amenorrhea: The effects of body composition and 54. Bishop N, Arundel P, Clark E, Dimitri P, Farr J, Jones G, Makitie O,
nutritional intake. J Clin Endocrinol Metab 1998;83:2309-2312. Munns CF, Shaw N; International Society of Clinical Densitometry.
36. Warren MP, Voussoughian F, Geer EB, Hyle EP, Adberg CL, Ramos RH. Fracture prediction and the definition of osteoporosis in children and
Functional hypothalamic amenorrhea: Hypoleptinemia and disordered adolescents: the ISCD 2013 Pediatric Official Positions. J Clin Densitom
eating. J Clin Endocrinol Metab 1999;84:873-877. 2014;17:275-280. Epub 2014 Mar 14
37. Chumlea WC, Schubert CM, Roche AF, Kulin HE, Lee PA, Himes JH, 55. No authors listed. ACOG Committee Opinion No. 651: Menstruation in
Sun SS. Age at menarche and racial comparisons in US girls. Pediatrics Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet
2003;111:110-113. Gynecol 2015;126:143-146.
38. No authors listed. World Health Organization multicenter study on 56. Popat VB, Prodanov T, Calis KA, Nelson LM. The menstrual cycle: a
menstrual and ovulatory patterns in adolescent girls. II. Longitudinal biological marker of general health in adolescents. Ann N Y Acad Sci
study of menstrual patterns in the early postmenarcheal period, 2008;1135:43-51.
duration of bleeding episodes and menstrual cycles. World Health 57. Kopp-Woodroffe SA, Manore MM, Dueck CA, Skinner JS, Matt KS.
Organization Task Force on Adolescent Reproductive Health. J Adolesc Energy and nutrient status of amenorrheic athletes participating in
Health Care 1986;7:236-244. a diet and exercise training intervention program. Int J Sport Nutr
39. Goldering JM, Rosen DS. Getting into adolescent heads: an essential 1999;9:70-88.
update. Contemp Pediatr 2004;21:64. 58. Lindberg JS, Powell MR, Hunt MM, Ducey DE, Wade CE. Increased
40. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in vertebral bone mineral in response to reduced exercise in amenorrheic
girls. Arch Dis Child 1969;44:291-303. runners. West J Med 1987;146:39-42.
41. Gordon CM, Ackerman KE, Berga SL, Kaplan JR, Mastorakos G, Misra 59. Javed A, Tebben PJ, Fischer PR, Lteif AN. Female Athlete Triad and its
M, Murad MH, Santoro NF, Warren MP. Functional hypothalamic components: Toward improved screening and management. Mayo Clin
amenorrhea: An Endocrine Society Clinical Practice Guideline. J Clin Proc 2013;88:996-1009.
Endocrinol Metab 2017;102:1413-1439. 60. Chen EC, Brzyski RG. Exercise and reproductive dysfunction. Fertil
42. La Marca A, Pati M, Orvieto R, Stabile G, Carducci Artenisio A, Volpe Steril 1999;71:1-6.
A. Serum anti-müllerian hormone levels in women with secondary 61. Berga SL, Marcus MD, Loucks TL, Hlastala S, Ringham R, Krohn MA.
amenorrhea. Fertil Steril 2006;85:1547-1549. Epub 2006 Apr 17 Recovery of ovarian activity in women with functional hypothalamic
43. Nakamura S, Douchi T, Oki T, Ijuin H, Yamamoto S, Nagata Y. Relationship amenorrhea who were treated with cognitive behavior therapy. Fertil
between sonographic endometrial thickness and progestin-induced Steril 2003;80:976-981.
withdrawal bleeding. Obstet Gynecol 1996;87:722-725. 62. Michopoulos V, Mancini F, Loucks TL, Berga SL. Neuroendocrine
44. Rarick LD, Shangold MM, Ahmed SW. Cervical mucus and serum recovery initiated by cognitive behavioral therapy in women with
estradiol as predictors of response to progestin challenge. Fertil Steril functional hypothalamic amenorrhea: a randomized, controlled trial.
1990;54:353-355. Fertil Steril 2013;99:2084-2091. Epub 2013 Mar 16
45. Olpin JD, Heilbrun M. Imaging of müllerian duct anomalies. Clin Obstet 63. Tschugguel W, Berga SL. Treatment of functional hypothalamic
Gynecol 2009;52:40-56. amenorrhea with hypnotherapy. Fertil Steril 2003;80:982-985.
46. Berger A, Batzer F, Lev-Toaff A, Berry-Roberts C. Diagnostic imaging 64. Cann CE, Genant HK, Ettinger B, Gordan GS. Spinal mineral loss in
modalities for müllerian anomalies: The case for a new gold standard. J oophorectomized women: determination by quantitative computed
Minim Invasive Gynecol 2014;21:335-345. Epub 2013 Nov 15 tomography. JAMA 1980;244:2056-2059.
47. Bermejo C, Martínez Ten P, Cantarero R, Diaz D, Pérez Pedregosa J, 65. Johansson BW, Kaij L, Kullander S, Lennér HC, Svanberg L, Åstedt B.
Barrón E, Labrador E, Ruiz López L. Three-dimensional ultrasound On some late effects of bilateral oophorectomy in the age range 15-30
in the diagnosis of Müllerian duct anomalies and concordance with years. Acta Obstet Gynecol Scand 1975;54:449-461.
magnetic resonance imaging. Ultrasound Obstet Gynecol 2010;35:593- 66. Liu SL, Lebrun CM. Effect of oral contraceptives and hormone
601. replacement therapy on bone mineral density in premenopausal and
48. Acharya SV, Gopal RA, Bandgar TR, Joshi SR, Menon PS, Shah NS. perimenopausal women: a systematic review. Br J Sports Med
Clinical profile and long term follow up of children and adolescents 2006;40:11-24.
with prolactinomas. Pituitary 2008;12:186-189. 67. Hergenroeder AC, Smith EO, Shypailo R, Jones LA, Klish WJ, Ellis
49. Miller KK, Klibanski A. Clinical review 106: Amenorrheic bone loss. J K. Bone mineral changes in young women with hypothalamic
Clin Endocrinol Metab 1999;84:1775-1783. amenorrhea treated with oral contraceptives, medroxyprogesterone,
50. Lawson EA, Donoho D, Miller KK, Misra M, Meenaghan E, Lydecker J, or placebo over 12 months. Am J Obstet Gynecol 1997;176:1017- 1025.
Wexler T, Herzog DB, Klibanski A. Hypercortisolemia Is associated with 68. Castelo-Branco C, Vicente JJ, Pons F, Martínez de Osaba MJ, Casals
severity of bone loss and depression in hypothalamic amenorrhea and E, Vanrell JA. Bone mineral density in young, hypothalamic
anorexia nervosa. J Clin Endocrinol Metab 2009;94:4710-4716. Epub oligoamenorrheic women treated with oral contraceptives. J Reprod
2009 Oct 16 Med 2001;46:875-879.
51. Warren MP, Brooks-Gunn J, Fox RP, Holderness CC, Hyle EP, Hamilton 69. De Crée C, Lewin R, Ostyn M. Suitability of cyproterone acetate in the
WG. Osteopenia in exercise-associated amenorrhea using balletdancers treatment of osteoporosis associated with athletic amenorrhea. Int J
as a model: A longitudinal study. J Clin Endocrinol Metab2002;87:3162- Sports Med 1988;9:187-192
3168. 70. Gulekli B, Davies MC, Jacobs HS. Effect of treatment on established
52. Lloyd T, Myers C, Buchanan JR, Demers LM. Collegiate women athletes osteoporosis in young women with amenorrhoea. Clin Endocrinol (Oxf)
with irregular menses during adolescence have decreased bone density. 1994;41:275-281.
Obstet Gynecol 1988;72:639-642.
26
J Clin Res Pediatr Endocrinol Gibson MES et al.
2020;12(Suppl 1):18-27 Functional Hypothalamic Amenorrhea
71. Haenggi W, Casez JP, Birkhaeuser MH, Lippuner K, Jaeger P. Bone amenorrhea and polycystic ovarian morphology. Gynecol Endocrinol
mineral density in young women with long-standing amenorrhea: 2016;32:999-1004. Epub 2016 Jun 3
limited effect of hormone replacement therapy with ethinylestradiol 85. Gompel A, Mauvais-Jarvis P. Induction of ovulation with pulsatile GnRH
and desogestrel. Osteoporos Int 1994;4:99-103. in hypothalamic amenorrhoea. Hum Reprod 1988;3:473-477.
72. Cumming DC. Exercise-associated amenorrhea, low bone density, and 86. Wildt L, Leyendecker G, Sir-Petermann T, Waibel-Treber S. Treatment
estrogen replacement therapy. Arch Intern Med 1996;156:2193- 2195. with naltrexone in hypothalamic ovarian failure: induction of ovulation
73. Rickenlund A, Carlström K, Ekblom B, Brismar TB, Von Schoultz B, and pregnancy. Hum Reprod 1993;8:350-358.
Hirschberg AL. Effects of oral contraceptives on body composition 87. Remorgida V, Venturini PL, Anserini P, Salerno E, De Cecco L.
and physical performance in female athletes. J Clin Endocrinol Metab Naltrexone in functional hypothalamic amenorrhea and in the normal
2004;89:4364-4370. Epub 2004 Aug 24 luteal phase. Obstet Gynecol 1990;76:1115-1120.
74. Gibson JH, Mitchell A, Reeve J, Harries MG. Treatment of reduced bone 88. Wildt L, Leyendecker G. Induction of ovulation by the chronic
mineral density in athletic amenorrhea: a pilot study. Osteoporos Int administration of naltrexone in hypothalamic amenorrhea. J Clin
1999;10:284-289. Endocrinol Metab 1987;64:1334-1335.
75. Gremion G, Rizzoli R, Slosman D, Theintz G, Bonjour JP. Oligo- 89. Leyendecker G, Waibel-Treber S, Wildt L. Pulsatile administration of
amenorrheic long-distance runners may lose more bone in spine than gonadotrophin releasing hormone and oral administration of
in femur. Med Sci Sports Exerc 2001;33:15-21. naltrexone in hypothalamic amenorrhoea. Hum Reprod 1993;8(Suppl
76. Zanker CL, Cooke CB, Truscott JG, Oldroyd B, Jacobs HS. Annual 2):184-188.
changes of bone density over 12 years in an amenorrheic athlete. Med 90. O’Donnell E, Goodman JM, Harvey PJ. Clinical review: Cardiovascular
Sci Sports Exerc 2004;36:137-142. consequences of ovarian disruption: A focus on functional hypothalamic
77. Misra M, Katzman D, Miller KK, Mendes N, Snelgrove D, Russell M, amenorrhea in physically active women. J Clin Endocrinol Metab
Goldstein MA, Ebrahimi S, Clauss L, Weigel T, Mickley D, Schoenfeld 2011;96:3638-3648. Epub 2011 Sep 28
DA, Herzog DB, Klibanski A. Physiologic estrogen replacement 91. Bairey Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein
increases bone density in adolescent girls with anorexia nervosa. J GD, Hodgson TK, Matthews KA, Pepine CJ, Reis SE, Reichek N, Rogers
Bone Miner Res 2011;26:2430-2438. WJ, Pohost GM, Kelsey SF, Sopko G; WISE Study Group.
78. Harel Z, Riggs S. Transdermal versus oral administration of estrogen Hypoestrogenemia of hypothalamic origin and coronary artery disease
in the management of lumbar spine osteopenia in an adolescent with in premenopausal women: a report from the NHLBI-sponsored WISE
anorexia nervosa. J Adolesc Health 1997;10:179-182. study. J Am Coll Cardiol 2003;41:413-419.
79. Ackerman KE, Singhal V, Baskaran C, Slattery M, Campoverde Reyes KJ, 92. Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, Hirschberg AL.
Toth A, Eddy KT, Bouxsein ML, Lee H, Klibanski A, Misra M. Oestrogen Amenorrhea in female athletes is associated with endothelial
replacement improves bone mineral density in oligo-amenorrhoeic dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab
athletes: a randomised clinical trial. Br J Sports Med 2019;53:229-236. 2005;90:1354-1359.
Epub 2018 Oct 9 93. Rickenlund A, Eriksson MJ, Schenck-Gustafsson K, Hirschberg AL. Oral
80. Hergenroeder AC. Bone mineralization, hypothalamic amenorrhea, contraceptives improve endothelial function in amenorrheic athletes. J
and sex steroid therapy in female adolescents and young adults. J Clin Endocrinol Metab 2005;90:3162-3167.
Pediatr 1995;126:683-689. 94. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A,
81. Vescovi JD, Jamal SA, De Souza MJ. Strategies to reverse bone loss in Mantzoros CS. Recombinant human leptin in women with
women with functional hypothalamic amenorrhea: a systematic review hypothalamic amenorrhea. N Engl J Med 2004;351:987-997.
of the literature. Osteoporos Int 2008;19:465-478. Epub 2008 Jan 8 95. Chou SH, Chamberland JP, Liu X, Matarese G, Gao C, Stefanakis R,
82. Martin KA, Hall JE, Adams JM, Crowley WF Jr. Comparison of exogenous Brinkoetter MT, Gong H, Arampatzi K, Mantzoros CS. Leptin is an
gonadotropins and pulsatile gonadotropin-releasing hormone for effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci
induction of ovulation in hypogonadotropic amenorrhea. J Clin U S A 2011;108:6585-6590. Epub 2011 Apr 4
Endocrinol Metab 1993;77:125-129. 96. Jayasena CN, Nijher GM, Chaudhri OB, Murphy KG, Ranger A, Lim
83. Christou F, Pitteloud N, Gomez F. The induction of ovulation by pulsatile A, Patel D, Mehta A, Todd C, Ramachandran R, Salem V, Stamp
administration of GnRH: an appropriate method in hypothalamic GW, Donaldson M, Ghatei MA, Bloom SR, Dhillo WS. Subcutaneous
amenorrhea. Gynecol Endocrinol 2017;33:598-601. Epub 2017 Mar 6 injection of kisspeptin-54 acutely stimulates gonadotropin secretion
84. Dumont A, Dewailly D, Plouvier P, Catteau-Jonard S, Robin G. in women with hypothalamic amenorrhea, but chronic administration
Comparison between pulsatile GnRH therapy and gonadotropins for causes tachyphylaxis. J Clin Endocrinol Metab 2009;94:4315-4323.
ovulation induction in women with both functional hypothalamic Epub 2009 Oct 9
27